<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:nuwe="http://sunshineheart.com/20260331"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="nuwe-20260331.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
        </entity>
        <period>
            <instant>2026-05-11</instant>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nuwe:SeriesJConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nuwe:SeriesJConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nuwe:SeriesF1ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nuwe:SeriesF1ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nuwe:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nuwe:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nuwe:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nuwe:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:SeriesFPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nuwe:SeriesF1ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nuwe:SeriesF1ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nuwe:SeriesJConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nuwe:SeriesJConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">nuwe:CommonStockAndWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nuwe:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-29</startDate>
            <endDate>2026-01-29</endDate>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nuwe:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-29</instant>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">nuwe:CommonAndPreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nuwe:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-29</startDate>
            <endDate>2026-01-29</endDate>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">nuwe:CommonAndPreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-29</instant>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">nuwe:CommonAndPreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nuwe:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-29</instant>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nuwe:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-29</instant>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">nuwe:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-29</startDate>
            <endDate>2026-01-29</endDate>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nuwe:ExistingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-29</instant>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">nuwe:InducementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-29</instant>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">nuwe:ExistingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-29</instant>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">nuwe:InducementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-29</startDate>
            <endDate>2026-01-29</endDate>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">nuwe:PlacementAgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-29</instant>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
        </entity>
        <period>
            <startDate>2026-01-29</startDate>
            <endDate>2026-01-29</endDate>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-29</instant>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-29</instant>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-29</instant>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-29</instant>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-29</instant>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
        </entity>
        <period>
            <instant>2026-01-29</instant>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">nuwe:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">nuwe:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nuwe:RendiatechLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-29</startDate>
            <endDate>2026-01-29</endDate>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nuwe:RendiatechLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-29</instant>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">nuwe:RendiatechLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nuwe:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">nuwe:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
        </entity>
        <period>
            <startDate>2025-07-03</startDate>
            <endDate>2025-07-03</endDate>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">nuwe:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">nuwe:PrivatePlacementCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">nuwe:PrivatePlacementCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">nuwe:InducementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">nuwe:AgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">nuwe:AgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">nuwe:RendiatechAssetAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">nuwe:RendiatechAssetAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nuwe:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nuwe:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nuwe:SeriesJWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">nuwe:SeriesJWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">nuwe:DeferredConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">nuwe:DeferredConsiderationLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">nuwe:WarrantLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">nuwe:DeferredConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">nuwe:WarrantLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nuwe:AcquisitionOfRendiatechInitialFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">nuwe:DeferredConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nuwe:AcquisitionOfRendiatechInitialFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nuwe:AcquisitionOfRendiatechInitialFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">nuwe:WarrantLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nuwe:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">nuwe:DeferredConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nuwe:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nuwe:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">nuwe:WarrantLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nuwe:June102025WarrantsIssuanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">nuwe:DeferredConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nuwe:June102025WarrantsIssuanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">nuwe:June102025WarrantsIssuanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">nuwe:WarrantLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">nuwe:DeferredConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">nuwe:FluidOverloadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">nuwe:FluidOverloadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">nuwe:RendiatechLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="c124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
        </entity>
        <period>
            <instant>2008-12-31</instant>
        </period>
    </context>
    <context id="c125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-24</startDate>
            <endDate>2026-04-24</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Customer">
        <measure>nuwe:Customer</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="Sqft">
        <measure>nuwe:Sqft</measure>
    </unit>
    <unit id="Segment">
        <measure>nuwe:Segment</measure>
    </unit>
    <dei:DocumentType contextRef="c0" id="ixv-5374">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c0" id="ixv-24">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c0" id="ixv-30">2026-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0" id="ixv-5375">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="c0" id="ixv-38">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c0" id="ixv-5376">001-35312</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-5377">NUWELLIS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0" id="ixv-66">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c0" id="ixv-5378">68-0533453</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c0" id="ixv-5379">12988 Valley View Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c0" id="ixv-5380">Eden Prairie</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c0" id="ixv-5381">MN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c0" id="ixv-5382">55344</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c0" id="ixv-5383">952</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c0" id="ixv-5384">345-4200</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c0" id="ixv-5385">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c0" id="ixv-5386">NUWE</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c0" id="ixv-5387">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c0" id="ixv-5388">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0" id="ixv-5389">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0" id="ixv-5390">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c0" id="ixv-174">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c0" id="ixv-5391">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c0" id="ixv-198">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c1"
      decimals="INF"
      id="ixv-5392"
      unitRef="shares">2680752</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c2" decimals="-3" id="ixv-5393" unitRef="usd">2083000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c3" decimals="-3" id="ixv-5394" unitRef="usd">1085000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c2" decimals="-3" id="ixv-5395" unitRef="usd">1559000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c3" decimals="-3" id="ixv-5396" unitRef="usd">1493000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="c2" decimals="-3" id="ixv-5397" unitRef="usd">1779000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c3" decimals="-3" id="ixv-5398" unitRef="usd">1910000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent contextRef="c2" decimals="-3" id="ixv-5399" unitRef="usd">406000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c3" decimals="-3" id="ixv-5400" unitRef="usd">698000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c2" decimals="-3" id="ixv-5401" unitRef="usd">5827000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c3" decimals="-3" id="ixv-5402" unitRef="usd">5186000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c2" decimals="-3" id="ixv-5403" unitRef="usd">365000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c3" decimals="-3" id="ixv-5404" unitRef="usd">368000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c2" decimals="-3" id="ixv-5405" unitRef="usd">237000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c3" decimals="-3" id="ixv-5406" unitRef="usd">293000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c2" decimals="-3" id="ixv-5407" unitRef="usd">112000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c3" decimals="-3" id="ixv-5408" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c2" decimals="-3" id="ixv-5409" unitRef="usd">420000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c3" decimals="-3" id="ixv-5410" unitRef="usd">271000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c2" decimals="-3" id="ixv-5411" unitRef="usd">6961000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c3" decimals="-3" id="ixv-5412" unitRef="usd">6118000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c2" decimals="-3" id="ixv-5413" unitRef="usd">2429000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c3" decimals="-3" id="ixv-5414" unitRef="usd">2226000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c2" decimals="-3" id="ixv-5415" unitRef="usd">852000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c3" decimals="-3" id="ixv-5416" unitRef="usd">460000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c2" decimals="-3" id="ixv-5417" unitRef="usd">265000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c3" decimals="-3" id="ixv-5418" unitRef="usd">261000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent contextRef="c2" decimals="-3" id="ixv-5419" unitRef="usd">113000</us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent>
    <us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent contextRef="c3" decimals="-3" id="ixv-5420" unitRef="usd">0</us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c2" decimals="-3" id="ixv-5421" unitRef="usd">71000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c3" decimals="-3" id="ixv-5422" unitRef="usd">85000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c2" decimals="-3" id="ixv-5423" unitRef="usd">3730000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c3" decimals="-3" id="ixv-5424" unitRef="usd">3032000</us-gaap:LiabilitiesCurrent>
    <us-gaap:AssetAcquisitionContingentConsiderationLiabilityNoncurrent contextRef="c2" decimals="-3" id="ixv-5425" unitRef="usd">200000</us-gaap:AssetAcquisitionContingentConsiderationLiabilityNoncurrent>
    <us-gaap:AssetAcquisitionContingentConsiderationLiabilityNoncurrent contextRef="c3" decimals="-3" id="ixv-5426" unitRef="usd">0</us-gaap:AssetAcquisitionContingentConsiderationLiabilityNoncurrent>
    <nuwe:CommonStockWarrantLiabilityNoncurrent contextRef="c2" decimals="-3" id="ixv-5427" unitRef="usd">362000</nuwe:CommonStockWarrantLiabilityNoncurrent>
    <nuwe:CommonStockWarrantLiabilityNoncurrent contextRef="c3" decimals="-3" id="ixv-5428" unitRef="usd">389000</nuwe:CommonStockWarrantLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c2" decimals="-3" id="ixv-5429" unitRef="usd">0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c3" decimals="-3" id="ixv-5430" unitRef="usd">67000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities contextRef="c2" decimals="-3" id="ixv-5431" unitRef="usd">4292000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c3" decimals="-3" id="ixv-5432" unitRef="usd">3488000</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c4"
      decimals="INF"
      id="ixv-5433"
      unitRef="usdPershares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c5"
      decimals="INF"
      id="ixv-5434"
      unitRef="usdPershares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c4"
      decimals="INF"
      id="ixv-5435"
      unitRef="shares">600000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c5"
      decimals="INF"
      id="ixv-5436"
      unitRef="shares">600000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c4"
      decimals="INF"
      id="ixv-5437"
      unitRef="shares">147</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c4"
      decimals="INF"
      id="ixv-5438"
      unitRef="shares">147</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c5"
      decimals="INF"
      id="ixv-5439"
      unitRef="shares">137</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c5"
      decimals="INF"
      id="ixv-5440"
      unitRef="shares">137</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c2" decimals="-3" id="ixv-5441" unitRef="usd">8000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c3" decimals="-3" id="ixv-5442" unitRef="usd">6000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c6"
      decimals="INF"
      id="ixv-5443"
      unitRef="usdPershares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c7"
      decimals="INF"
      id="ixv-5444"
      unitRef="usdPershares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c6"
      decimals="INF"
      id="ixv-5445"
      unitRef="shares">30000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c7"
      decimals="INF"
      id="ixv-5446"
      unitRef="shares">30000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c6"
      decimals="INF"
      id="ixv-5447"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c7"
      decimals="INF"
      id="ixv-5448"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c6" decimals="-3" id="ixv-5449" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c7" decimals="-3" id="ixv-5450" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c8"
      decimals="INF"
      id="ixv-5451"
      unitRef="usdPershares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c9"
      decimals="INF"
      id="ixv-5452"
      unitRef="usdPershares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c8"
      decimals="INF"
      id="ixv-5453"
      unitRef="shares">18000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c9"
      decimals="INF"
      id="ixv-5454"
      unitRef="shares">18000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c8"
      decimals="INF"
      id="ixv-5455"
      unitRef="shares">27</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c8"
      decimals="INF"
      id="ixv-5456"
      unitRef="shares">27</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c9"
      decimals="INF"
      id="ixv-5457"
      unitRef="shares">127</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c9"
      decimals="INF"
      id="ixv-5458"
      unitRef="shares">127</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c8" decimals="-3" id="ixv-5459" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c9" decimals="-3" id="ixv-5460" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c10"
      decimals="INF"
      id="ixv-5461"
      unitRef="usdPershares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c11"
      decimals="INF"
      id="ixv-5462"
      unitRef="usdPershares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c10"
      decimals="INF"
      id="ixv-5463"
      unitRef="shares">100</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c11"
      decimals="INF"
      id="ixv-5464"
      unitRef="shares">100</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c10"
      decimals="INF"
      id="ixv-5465"
      unitRef="shares">34</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c10"
      decimals="INF"
      id="ixv-5466"
      unitRef="shares">34</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c11"
      decimals="INF"
      id="ixv-5467"
      unitRef="shares">34</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c11"
      decimals="INF"
      id="ixv-5468"
      unitRef="shares">34</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c10" decimals="-3" id="ixv-5469" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c11" decimals="-3" id="ixv-5470" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c2"
      decimals="INF"
      id="ixv-5471"
      unitRef="usdPershares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c3"
      decimals="INF"
      id="ixv-5472"
      unitRef="usdPershares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c2"
      decimals="INF"
      id="ixv-5473"
      unitRef="shares">39352000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c3"
      decimals="INF"
      id="ixv-5474"
      unitRef="shares">39352000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c2"
      decimals="INF"
      id="ixv-5475"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c3"
      decimals="INF"
      id="ixv-5476"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c2" decimals="-3" id="ixv-5477" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c3" decimals="-3" id="ixv-5478" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c2"
      decimals="INF"
      id="ixv-5479"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c3"
      decimals="INF"
      id="ixv-5480"
      unitRef="usdPershares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c2"
      decimals="INF"
      id="ixv-5481"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c3"
      decimals="INF"
      id="ixv-5482"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="c2"
      decimals="INF"
      id="ixv-5483"
      unitRef="shares">2635718</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c2"
      decimals="INF"
      id="ixv-5484"
      unitRef="shares">2635718</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c3"
      decimals="INF"
      id="ixv-5485"
      unitRef="shares">1686217</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c3"
      decimals="INF"
      id="ixv-5486"
      unitRef="shares">1686217</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c2" decimals="-3" id="ixv-5487" unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c3" decimals="-3" id="ixv-5488" unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c2" decimals="-3" id="ixv-5489" unitRef="usd">323506000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c3" decimals="-3" id="ixv-5490" unitRef="usd">318928000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="c2" decimals="-3" id="ixv-5491" unitRef="usd">8000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="c3" decimals="-3" id="ixv-5492" unitRef="usd">8000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c2" decimals="-3" id="ixv-5493" unitRef="usd">-320853000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c3" decimals="-3" id="ixv-5494" unitRef="usd">-316312000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c2" decimals="-3" id="ixv-5495" unitRef="usd">2661000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c3" decimals="-3" id="ixv-5496" unitRef="usd">2624000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c2" decimals="-3" id="ixv-5497" unitRef="usd">6961000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c3" decimals="-3" id="ixv-5498" unitRef="usd">6118000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c0" decimals="-3" id="ixv-5499" unitRef="usd">2403000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c12" decimals="-3" id="ixv-5500" unitRef="usd">1904000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c0" decimals="-3" id="ixv-5501" unitRef="usd">719000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c12" decimals="-3" id="ixv-5502" unitRef="usd">837000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit contextRef="c0" decimals="-3" id="ixv-5503" unitRef="usd">1684000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c12" decimals="-3" id="ixv-5504" unitRef="usd">1067000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c0" decimals="-3" id="ixv-5505" unitRef="usd">4524000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c12" decimals="-3" id="ixv-5506" unitRef="usd">3577000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c0" decimals="-3" id="ixv-5507" unitRef="usd">1728000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c12" decimals="-3" id="ixv-5508" unitRef="usd">550000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses contextRef="c0" decimals="-3" id="ixv-5509" unitRef="usd">6252000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c12" decimals="-3" id="ixv-5510" unitRef="usd">4127000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c0" decimals="-3" id="ixv-5511" unitRef="usd">-4568000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c12" decimals="-3" id="ixv-5512" unitRef="usd">-3060000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c0" decimals="-3" id="ixv-5513" unitRef="usd">1000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c12" decimals="-3" id="ixv-5514" unitRef="usd">7000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c0" decimals="-3" id="ixv-5515" unitRef="usd">-26000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c12" decimals="-3" id="ixv-5516" unitRef="usd">-40000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c0" decimals="-3" id="ixv-5517" unitRef="usd">-4541000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c12" decimals="-3" id="ixv-5518" unitRef="usd">-3013000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c0" decimals="-3" id="ixv-5519" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c12" decimals="-3" id="ixv-5520" unitRef="usd">1000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-5521" unitRef="usd">-4541000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c12" decimals="-3" id="ixv-5522" unitRef="usd">-3014000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquityDividendsAdjustment contextRef="c0" decimals="-3" id="ixv-5523" unitRef="usd">-2000</us-gaap:TemporaryEquityDividendsAdjustment>
    <us-gaap:TemporaryEquityDividendsAdjustment contextRef="c12" decimals="-3" id="ixv-5524" unitRef="usd">-1000</us-gaap:TemporaryEquityDividendsAdjustment>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c0" decimals="-3" id="ixv-5525" unitRef="usd">-4539000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c12" decimals="-3" id="ixv-5526" unitRef="usd">-3013000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c0"
      decimals="2"
      id="ixv-5527"
      unitRef="usdPershares">-2.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c0"
      decimals="2"
      id="ixv-5528"
      unitRef="usdPershares">-2.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c12"
      decimals="2"
      id="ixv-5529"
      unitRef="usdPershares">-28.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c12"
      decimals="2"
      id="ixv-5530"
      unitRef="usdPershares">-28.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c0" decimals="0" id="ixv-5531" unitRef="shares">2074940</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c0" decimals="0" id="ixv-5532" unitRef="shares">2074940</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c12"
      decimals="0"
      id="ixv-5533"
      unitRef="shares">104142</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c12"
      decimals="0"
      id="ixv-5534"
      unitRef="shares">104142</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-5535" unitRef="usd">-4541000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c12" decimals="-3" id="ixv-5536" unitRef="usd">-3014000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c0" decimals="-3" id="ixv-5537" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c12" decimals="-3" id="ixv-5538" unitRef="usd">-2000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c0" decimals="-3" id="ixv-5539" unitRef="usd">-4541000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c12" decimals="-3" id="ixv-5540" unitRef="usd">-3016000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="c13"
      decimals="INF"
      id="ixv-5541"
      unitRef="shares">104142</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c13" decimals="-3" id="ixv-5542" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c14" decimals="-3" id="ixv-5543" unitRef="usd">305366000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c15" decimals="-3" id="ixv-5544" unitRef="usd">-47000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c16" decimals="-3" id="ixv-5545" unitRef="usd">-298791000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c17" decimals="-3" id="ixv-5546" unitRef="usd">6528000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c18" decimals="-3" id="ixv-5547" unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c19" decimals="-3" id="ixv-5548" unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c20" decimals="-3" id="ixv-5549" unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c21" decimals="-3" id="ixv-5550" unitRef="usd">-3014000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c12" decimals="-3" id="ixv-5551" unitRef="usd">-3014000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c18" decimals="-3" id="ixv-5552" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c19" decimals="-3" id="ixv-5553" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c20" decimals="-3" id="ixv-5554" unitRef="usd">-2000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c21" decimals="-3" id="ixv-5555" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="c12" decimals="-3" id="ixv-5556" unitRef="usd">-2000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c18"
      decimals="INF"
      id="ixv-5557"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c18" decimals="-3" id="ixv-5558" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c19" decimals="-3" id="ixv-5559" unitRef="usd">67000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c20" decimals="-3" id="ixv-5560" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c21" decimals="-3" id="ixv-5561" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c12" decimals="-3" id="ixv-5562" unitRef="usd">67000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <nuwe:AdjustmentsToAdditionalPaidInCapitalDeemedDividend contextRef="c18" decimals="-3" id="ixv-5563" unitRef="usd">0</nuwe:AdjustmentsToAdditionalPaidInCapitalDeemedDividend>
    <nuwe:AdjustmentsToAdditionalPaidInCapitalDeemedDividend contextRef="c19" decimals="-3" id="ixv-5564" unitRef="usd">-1000</nuwe:AdjustmentsToAdditionalPaidInCapitalDeemedDividend>
    <nuwe:AdjustmentsToAdditionalPaidInCapitalDeemedDividend contextRef="c20" decimals="-3" id="ixv-5565" unitRef="usd">0</nuwe:AdjustmentsToAdditionalPaidInCapitalDeemedDividend>
    <nuwe:AdjustmentsToAdditionalPaidInCapitalDeemedDividend contextRef="c21" decimals="-3" id="ixv-5566" unitRef="usd">0</nuwe:AdjustmentsToAdditionalPaidInCapitalDeemedDividend>
    <nuwe:AdjustmentsToAdditionalPaidInCapitalDeemedDividend contextRef="c12" decimals="-3" id="ixv-5567" unitRef="usd">-1000</nuwe:AdjustmentsToAdditionalPaidInCapitalDeemedDividend>
    <us-gaap:SharesOutstanding
      contextRef="c22"
      decimals="INF"
      id="ixv-5568"
      unitRef="shares">104142</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c22" decimals="-3" id="ixv-5569" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c23" decimals="-3" id="ixv-5570" unitRef="usd">305432000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c24" decimals="-3" id="ixv-5571" unitRef="usd">-49000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c25" decimals="-3" id="ixv-5572" unitRef="usd">-301805000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c26" decimals="-3" id="ixv-5573" unitRef="usd">3578000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="c27"
      decimals="INF"
      id="ixv-5574"
      unitRef="shares">1686217</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c27" decimals="-3" id="ixv-5575" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c28" decimals="-3" id="ixv-5576" unitRef="usd">318928000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c29" decimals="-3" id="ixv-5577" unitRef="usd">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c30" decimals="-3" id="ixv-5578" unitRef="usd">-316312000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c3" decimals="-3" id="ixv-5579" unitRef="usd">2624000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c31" decimals="-3" id="ixv-5580" unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c32" decimals="-3" id="ixv-5581" unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c33" decimals="-3" id="ixv-5582" unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c34" decimals="-3" id="ixv-5583" unitRef="usd">-4541000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-5584" unitRef="usd">-4541000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c31"
      decimals="INF"
      id="ixv-5585"
      unitRef="shares">799501</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <nuwe:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="c31" decimals="-3" id="ixv-5586" unitRef="usd">0</nuwe:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <nuwe:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="c32" decimals="-3" id="ixv-5587" unitRef="usd">4393000</nuwe:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <nuwe:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="c33" decimals="-3" id="ixv-5588" unitRef="usd">0</nuwe:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <nuwe:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="c34" decimals="-3" id="ixv-5589" unitRef="usd">0</nuwe:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <nuwe:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="c0" decimals="-3" id="ixv-5590" unitRef="usd">4393000</nuwe:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c31"
      decimals="INF"
      id="ixv-5591"
      unitRef="shares">150000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c31" decimals="-3" id="ixv-5592" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c32" decimals="-3" id="ixv-5593" unitRef="usd">162000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c33" decimals="-3" id="ixv-5594" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c34" decimals="-3" id="ixv-5595" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c0" decimals="-3" id="ixv-5596" unitRef="usd">162000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c31"
      decimals="INF"
      id="ixv-5597"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c31" decimals="-3" id="ixv-5598" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c32" decimals="-3" id="ixv-5599" unitRef="usd">25000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c33" decimals="-3" id="ixv-5600" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c34" decimals="-3" id="ixv-5601" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c0" decimals="-3" id="ixv-5602" unitRef="usd">25000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <nuwe:AdjustmentsToAdditionalPaidInCapitalDeemedDividend contextRef="c31" decimals="-3" id="ixv-5603" unitRef="usd">0</nuwe:AdjustmentsToAdditionalPaidInCapitalDeemedDividend>
    <nuwe:AdjustmentsToAdditionalPaidInCapitalDeemedDividend contextRef="c32" decimals="-3" id="ixv-5604" unitRef="usd">-2000</nuwe:AdjustmentsToAdditionalPaidInCapitalDeemedDividend>
    <nuwe:AdjustmentsToAdditionalPaidInCapitalDeemedDividend contextRef="c33" decimals="-3" id="ixv-5605" unitRef="usd">0</nuwe:AdjustmentsToAdditionalPaidInCapitalDeemedDividend>
    <nuwe:AdjustmentsToAdditionalPaidInCapitalDeemedDividend contextRef="c34" decimals="-3" id="ixv-5606" unitRef="usd">0</nuwe:AdjustmentsToAdditionalPaidInCapitalDeemedDividend>
    <nuwe:AdjustmentsToAdditionalPaidInCapitalDeemedDividend contextRef="c0" decimals="-3" id="ixv-5607" unitRef="usd">-2000</nuwe:AdjustmentsToAdditionalPaidInCapitalDeemedDividend>
    <us-gaap:SharesOutstanding
      contextRef="c35"
      decimals="INF"
      id="ixv-5608"
      unitRef="shares">2635718</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c35" decimals="-3" id="ixv-5609" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c36" decimals="-3" id="ixv-5610" unitRef="usd">323506000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c37" decimals="-3" id="ixv-5611" unitRef="usd">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c38" decimals="-3" id="ixv-5612" unitRef="usd">-320853000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c2" decimals="-3" id="ixv-5613" unitRef="usd">2661000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-5614" unitRef="usd">-4541000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c12" decimals="-3" id="ixv-5615" unitRef="usd">-3014000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization contextRef="c0" decimals="-3" id="ixv-5616" unitRef="usd">38000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c12" decimals="-3" id="ixv-5617" unitRef="usd">73000</us-gaap:DepreciationAndAmortization>
    <us-gaap:ShareBasedCompensation contextRef="c0" decimals="-3" id="ixv-5618" unitRef="usd">25000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c12" decimals="-3" id="ixv-5619" unitRef="usd">67000</us-gaap:ShareBasedCompensation>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c0" decimals="-3" id="ixv-5620" unitRef="usd">-26000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c12" decimals="-3" id="ixv-5621" unitRef="usd">-40000</us-gaap:FairValueAdjustmentOfWarrants>
    <nuwe:NoncashInProcessResearchAndDevelopmentfromRendiatechAcquisition contextRef="c0" decimals="-3" id="ixv-5622" unitRef="usd">757000</nuwe:NoncashInProcessResearchAndDevelopmentfromRendiatechAcquisition>
    <nuwe:NoncashInProcessResearchAndDevelopmentfromRendiatechAcquisition contextRef="c12" decimals="-3" id="ixv-5623" unitRef="usd">0</nuwe:NoncashInProcessResearchAndDevelopmentfromRendiatechAcquisition>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c0" decimals="-3" id="ixv-5624" unitRef="usd">66000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c12" decimals="-3" id="ixv-5625" unitRef="usd">-187000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c0" decimals="-3" id="ixv-5626" unitRef="usd">-181000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c12" decimals="-3" id="ixv-5627" unitRef="usd">34000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="c0" decimals="-3" id="ixv-5628" unitRef="usd">-293000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="c12" decimals="-3" id="ixv-5629" unitRef="usd">-41000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet contextRef="c0" decimals="-3" id="ixv-5630" unitRef="usd">171000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet contextRef="c12" decimals="-3" id="ixv-5631" unitRef="usd">-45000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c0" decimals="-3" id="ixv-5632" unitRef="usd">398000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c12" decimals="-3" id="ixv-5633" unitRef="usd">139000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" decimals="-3" id="ixv-5634" unitRef="usd">-3112000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c12" decimals="-3" id="ixv-5635" unitRef="usd">-2536000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c0" decimals="-3" id="ixv-5636" unitRef="usd">30000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c12" decimals="-3" id="ixv-5637" unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c0" decimals="-3" id="ixv-5638" unitRef="usd">90000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c12" decimals="-3" id="ixv-5639" unitRef="usd">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c0" decimals="-3" id="ixv-5640" unitRef="usd">164000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c12" decimals="-3" id="ixv-5641" unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c0" decimals="-3" id="ixv-5642" unitRef="usd">-284000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c12" decimals="-3" id="ixv-5643" unitRef="usd">0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c0" decimals="-3" id="ixv-5644" unitRef="usd">4393000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c12" decimals="-3" id="ixv-5645" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <nuwe:NoncashSeriesJDeemedDividend contextRef="c0" decimals="-3" id="ixv-5646" unitRef="usd">2000</nuwe:NoncashSeriesJDeemedDividend>
    <nuwe:NoncashSeriesJDeemedDividend contextRef="c12" decimals="-3" id="ixv-5647" unitRef="usd">0</nuwe:NoncashSeriesJDeemedDividend>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c0" decimals="-3" id="ixv-5648" unitRef="usd">4395000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c12" decimals="-3" id="ixv-5649" unitRef="usd">0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c0" decimals="-3" id="ixv-5650" unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c12" decimals="-3" id="ixv-5651" unitRef="usd">-2000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c0" decimals="-3" id="ixv-5652" unitRef="usd">999000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c12" decimals="-3" id="ixv-5653" unitRef="usd">-2538000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c3" decimals="-3" id="ixv-5654" unitRef="usd">1190000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c17" decimals="-3" id="ixv-5655" unitRef="usd">5095000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c2" decimals="-3" id="ixv-5656" unitRef="usd">2189000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c26" decimals="-3" id="ixv-5657" unitRef="usd">2557000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <nuwe:CommonStockIssuedAsConsiderationInAssetAcquisition contextRef="c0" decimals="-3" id="ixv-5658" unitRef="usd">162000</nuwe:CommonStockIssuedAsConsiderationInAssetAcquisition>
    <nuwe:CommonStockIssuedAsConsiderationInAssetAcquisition contextRef="c12" decimals="-3" id="ixv-5659" unitRef="usd">0</nuwe:CommonStockIssuedAsConsiderationInAssetAcquisition>
    <nuwe:TransactionCostsInAccountsPayable contextRef="c0" decimals="-3" id="ixv-5660" unitRef="usd">164000</nuwe:TransactionCostsInAccountsPayable>
    <nuwe:TransactionCostsInAccountsPayable contextRef="c12" decimals="-3" id="ixv-5661" unitRef="usd">0</nuwe:TransactionCostsInAccountsPayable>
    <nuwe:DeferredCostsIssuedAsConsiderationInAssetAcquisition contextRef="c0" decimals="-3" id="ixv-5662" unitRef="usd">313000</nuwe:DeferredCostsIssuedAsConsiderationInAssetAcquisition>
    <us-gaap:TemporaryEquityDividendsAdjustment contextRef="c0" decimals="-3" id="ixv-5663" unitRef="usd">-2000</us-gaap:TemporaryEquityDividendsAdjustment>
    <us-gaap:TemporaryEquityDividendsAdjustment contextRef="c12" decimals="-3" id="ixv-5664" unitRef="usd">-1000</us-gaap:TemporaryEquityDividendsAdjustment>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock contextRef="c0" id="ixv-2199">&lt;div style="font-size: 10pt; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif;"&gt;
   &lt;span style="font-weight: bold;"&gt;Note 1 &#x2013; Nature of Business and Basis of Presentation&lt;/span&gt;
  &lt;/div&gt;
  &lt;div style="font-size: 10pt; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif;"&gt;&#160;
  &lt;/div&gt;
  &lt;div style="font-size: 10pt; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif;"&gt;
   &lt;span style="font-style: italic;"&gt;Nature of Business:&lt;/span&gt;&#160;Nuwellis, Inc. (the &#x201c;Company&#x201d;) is a commercial-stage medical device company focused on advancing precision cardiorenal care in critical care settings, through the development, manufacture and commercialization of the Aquadex SmartFlow&#xae; system for ultrafiltration therapy. The Aquadex SmartFlow&#xae; system is indicated for temporary (up to eight hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kg or more, whose fluid overload is unresponsive to medical management, including diuretics. Nuwellis, Inc. is a Delaware corporation headquartered in Minneapolis with a wholly owned subsidiary in Ireland which we are in the process of dissolving, along with another subsidiary incorporated under the laws of Israel. The Company has been listed on Nasdaq since February 2012.
  &lt;/div&gt;
  &lt;div style="font-size: 10pt; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif;"&gt;&#160;
  &lt;/div&gt;
  &lt;div style="font-size: 10pt; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif;"&gt;
   &lt;span style="color: rgb(0, 0, 0);"&gt;In August 2016, the Company acquired the business associated with the Aquadex System (the &#x201c;Aquadex Business&#x201d;) from a subsidiary of Baxter International, Inc. (&#x201c;Baxter&#x201d;) and refocused its strategy to fully devote its resources to the Aquadex Business. On April 27, 2021, the Company announced that it was changing its name from CHF Solutions, Inc. to Nuwellis, Inc. to reflect the expansion of its customer base from treating fluid imbalance resulting from congestive heart failure to also include critical care and pediatrics applications.&lt;/span&gt;
  &lt;/div&gt;

  &lt;div style="font-size: 10pt; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif;"&gt;&#160;&lt;/div&gt;
  &lt;div style="margin: 0in;"&gt;In March, 2026, the Company acquired Rendiatech, Inc. (an
Israeli corporation formed to acquire certain assets of RenalSense Ltd.
following its bankruptcy), which develops automated kidney function monitoring
technology. See Note 10 &#x2013; Asset Acquisition for additional details.&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif;"&gt;&#160;&lt;/div&gt;
  &lt;div style="font-size: 10pt; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif;"&gt; &lt;span style="font-style: italic;"&gt;Principles of Consolidation: &lt;/span&gt;The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. GAAP for interim financial information and do not include all disclosures required by GAAP for annual financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2025. The results of operations for the three months ended March 31, 2026 are not necessarily indicative of the results expected for the full year. &lt;/div&gt;
  &lt;div style="font-size: 10pt; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif;"&gt;&#160;&lt;/div&gt;
  &lt;div style="margin: 0in;"&gt;&lt;i style="mso-bidi-font-style:normal"&gt;Acquisitions: &lt;/i&gt;The Company evaluates
acquisitions pursuant to ASC 805, Business Combinations, to determine whether
the transaction should be accounted for as a business combination or an asset
acquisition.&lt;/div&gt;&lt;div style="margin: 0in;"&gt;&#160;&lt;/div&gt;&lt;div style="margin: 0in;"&gt;For
asset acquisitions, the Company allocates the purchase price (including
transaction costs) to the individual assets acquired and liabilities assumed on
a relative fair value basis. Direct acquisition-related costs are capitalized
as part of the purchase price.&lt;/div&gt;&lt;div style="margin: 0in;"&gt;&#160;&lt;/div&gt;&lt;div style="margin: 0in;"&gt;&lt;i&gt;Acquired
In-Process Research and Development Expenses:&lt;/i&gt;&lt;span style="font-size:12.0pt"&gt;
&lt;/span&gt;Acquired in-process research and development activities include payments
pursuant to the Company&#x2019;s asset acquisition. In-process research and
development that is acquired in a transaction that does not qualify as a
business combination under U.S. GAAP and that does not have an alternative
future use is recorded as Research and Development expense in the consolidated
statements of operations in the period in which it is acquired.&lt;span style="mso-spacerun:yes"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin: 0in;"&gt;&#160;&lt;/div&gt;&lt;div style="margin: 0in;"&gt;The
Company expensed $757 thousand of acquired in-process research and development
related to the Rendiatech asset acquisition during the three months ended March
31, 2026, as it had no alternative future use.&lt;/div&gt;&lt;div style="margin: 0in;"&gt;&#160;&lt;/div&gt;&lt;div style="margin: 0in;"&gt;&lt;i style="mso-bidi-font-style:normal"&gt;Intangible Assets:&lt;/i&gt;&lt;span style="font-size:12.0pt"&gt; &lt;/span&gt;Intangible assets&lt;span style="mso-spacerun:yes"&gt;&#160; &lt;/span&gt;comprise non-competition agreements and
website development costs. Intangible assets with finite lives are amortized
over the period the assets are expected to contribute directly or indirectly to
future cash flows.&lt;/div&gt;






  &lt;div style="font-size: 10pt; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif;"&gt;&#160;
  &lt;/div&gt;
  &lt;div style="font-size: 10pt; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif;"&gt;
   Intangible assets are reviewed for impairment annually or more frequently if indicators of impairment exist.
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &lt;span style="font-style: italic;"&gt;Going Concern:&lt;/span&gt;&lt;span style="font-weight: bold; font-style: italic;"&gt;&#160;&lt;/span&gt;The Company&#x2019;s condensed consolidated financial statements have been prepared assuming it will continue as a going concern. As of March 31, 2026, the Company had an accumulated deficit of $320.9 million and expects to continue incurring losses in the near term. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   To date, the Company has been funded primarily through equity financings. The Company believes its existing capital resources will be sufficient to support its operating plan into the second quarter of 2026. It will also continue to evaluate opportunities to raise additional capital through debt, equity, or a combination thereof to support growth initiatives and strengthen its balance sheet. While the Company is confident in its ability to fund operations and execute on its strategic plan, there can be no assurance that additional capital will be available on favorable terms, or at all, or that the Company will achieve profitability.
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   These conditions, including continued operating losses, negative cash flows from operations, an accumulated deficit of $320.9 million, and the need for additional capital to fund ongoing operations and growth initiatives (including the integration of the Rendiatech acquisition), raise substantial doubt about the Company&#x2019;s ability to continue as a going concern for at least twelve months from the date these financial statements are issued. While management&#x2019;s plans, including recent financing activities, cost discipline initiatives, and contingency measures, are intended to address these conditions, such plans do not alleviate the substantial doubt. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &lt;span style="font-style: italic;"&gt;Segment Information&lt;/span&gt;: Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision-maker in deciding how to allocate resources and assess performance. The Company and the Company&#x2019;s chief operating decision-maker (the &#x201c;CODM&#x201d;), the chief executive officer, view the Company&#x2019;s operations and manages its business as a single operating segment. On March 31, 2026 and December 31, 2025, long-lived assets were located primarily in the United States. See Note 9 &#x2014; Segment Reporting for additional information. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &lt;span style="font-style: italic;"&gt;Revenue Recognition: &lt;/span&gt;The Company recognizes revenue in accordance with Accounting Standards Codification, Topic 606, Revenue from Contracts with Customers, which the Company adopted effective January 1, 2018. Accordingly, the Company recognizes revenue when its customers obtain control of its products or services, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods and services. See Note 2 &#x2013; Revenue Recognition below for additional disclosures. For the three months ended March 31, 2026, three customer represented 14%, 11%, and 10% of net sales. For the three months ended March 31, 2025, one customer represented 14% of net sales. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; Inventories consisted of the following: &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;
   &lt;tr style="height: 0px; font-size: 0px;"&gt;
    &lt;td style="width: 76%;"&gt;&#160;&lt;/td&gt;


    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;



    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;

   &lt;/tr&gt;

   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: bottom;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      &lt;span style="font-style: italic;"&gt;(in thousands)&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align: bottom; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; text-align: center;"&gt;
     &lt;div&gt;
      &lt;span style="font-weight: bold;"&gt;March 31,&lt;br/&gt; 2026&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;&lt;td colspan="1" style="vertical-align: bottom; border-width: medium; border-style: none; border-color: currentcolor; white-space: nowrap; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;


    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align: bottom; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; width: 1%; text-align: center;"&gt;
     &lt;div&gt;
      &lt;span style="font-weight: bold;"&gt;December 31,&lt;br/&gt; 2025&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;&lt;td colspan="1" style="vertical-align: bottom; border-width: medium; border-style: none; border-color: currentcolor; white-space: nowrap; width: 1%;"&gt;&#160;&lt;/td&gt;

   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="text-align: left;"&gt;Finished Goods&lt;/td&gt;


    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%;"&gt;285&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;



    &lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%;"&gt;445&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;

   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Work in Process
     &lt;/div&gt;
    &lt;/td&gt;


    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%;"&gt;138&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;



    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%;"&gt;88&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;

   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Raw Materials
     &lt;/div&gt;
    &lt;/td&gt;


    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%;"&gt;1,449&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;



    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%;"&gt;1,457&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;

   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Inventory Reserves
     &lt;/div&gt;
    &lt;/td&gt;


    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid black;"&gt;(93&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid transparent;"&gt;)&#160;&lt;/td&gt;



    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid black;"&gt;(80&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid transparent;"&gt;)&#160;&lt;/td&gt;

   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="padding-left: 10px;"&gt;
     &lt;div&gt;
      Total
     &lt;/div&gt;
    &lt;/td&gt;


    &lt;td style="vertical-align: bottom; text-decoration: underline; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 4px double black;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double black;"&gt;1,779&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 4px double transparent;"&gt;&#160;&lt;/td&gt;



    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 4px double black;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double black;"&gt;1,910&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 4px double transparent;"&gt;&#160;&lt;/td&gt;

   &lt;/tr&gt;
  &lt;/table&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &lt;span style="font-style: italic;"&gt;Loss per Share:&lt;/span&gt;&#160;Basic loss per share is computed based on the net loss for each period divided by the weighted average number of common shares outstanding. See Note 3 &#x2013; Stockholders&#x2019; Equity below for additional disclosures. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   Diluted earnings per share is computed based on the net loss allocable to common stockholders for each period divided by the weighted average number of common shares outstanding, increased by the number of additional shares that would have been outstanding had the potentially dilutive common shares been issued, and reduced by the number of shares the Company could have repurchased from the proceeds from issuance of the potentially dilutive shares. Potentially dilutive shares of common stock include shares underlying outstanding convertible preferred stock, warrants, stock options and other stock-based awards granted under stock-based compensation plans.
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; The following table sets forth the potential shares of common stock that are not included in the calculation of diluted net loss per share because to do so would be anti-dilutive as of the end of each period presented: &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;
 &lt;tr style="height: 0px; font-size: 0px;"&gt;
  &lt;td style="height: 1pt; width: 76%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; width: 9%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; width: 9%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:1;height:1.0pt"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td colspan="6" style="width: 1%; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); text-align: center;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;&lt;b style="mso-bidi-font-weight:   normal"&gt;March 31&lt;/b&gt;&lt;/div&gt;
      &lt;/td&gt;
  &lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:2;height:1.0pt"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%; text-align: center;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;&lt;b style="mso-bidi-font-weight:   normal"&gt;2026&lt;/b&gt;&lt;/div&gt;
  &lt;/td&gt;&lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%; text-align: center;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;&lt;b style="mso-bidi-font-weight:   normal"&gt;2025&lt;/b&gt;&lt;/div&gt;
  &lt;/td&gt;&lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="height: 1pt; background-color: rgb(204, 238, 255);"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;Stock options&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%;" valign="top"&gt;34,446&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%;" valign="top"&gt;81&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:4;height:1.0pt"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;Warrants to purchase common
  stock&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%;" valign="top"&gt;4,815,296&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%;" valign="top"&gt;126,787&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="height: 1pt; background-color: rgb(204, 238, 255);"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;Series F convertible preferred
  stock&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%;" valign="top"&gt;10,719&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%;" valign="top"&gt;1,642&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;&lt;tr&gt;
  &lt;td valign="top"&gt;Series F-1
convertible preferred stock&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: right; width: 9%;" valign="top"&gt;13,498&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: right; width: 9%;" valign="top"&gt;&#x2014;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;

 &lt;tr style="height: 1pt; background-color: rgb(204, 238, 255);"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;Series J convertible preferred
  stock&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-bottom: 2px solid black;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%; border-bottom: 2px solid black;" valign="top"&gt;87&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-bottom: 2px solid black;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%; border-bottom: 2px solid black;" valign="top"&gt;2&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="height: 1pt;"&gt;
  &lt;td style="height: 1pt; padding-left: 10px;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;Total&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-width: medium medium 4px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%; border-width: medium medium 4px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" valign="top"&gt;4,874,046&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-width: medium medium 4px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%; border-width: medium medium 4px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" valign="top"&gt;128,512&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
&lt;/table&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; The following table reconciles reported net loss with reported net loss per share for each of the three months ended: &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;table cellpadding="0" style="font-size: 10pt; border-collapse: collapse; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;
   &lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td style="width: 76%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;


    &lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="font-size: 0px;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="6" style="width: 1%; vertical-align: bottom; text-align: center; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; border-width: medium medium 2px; border-style: none none solid;"&gt;



      &lt;span style="font-weight: bold;"&gt;Three months ended&lt;br/&gt;

      March 31&lt;/span&gt;
         &lt;/td&gt;

    &lt;td style="border-width: medium; border-style: none; border-color: currentcolor; text-align: center; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="font-size: 0px;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="width: 1%; vertical-align: bottom; text-align: center; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;


      &lt;span style="font-weight: bold;"&gt;2026&lt;/span&gt;
     &lt;/td&gt;


    &lt;td style="border-width: medium; border-style: none; border-color: currentcolor; text-align: center; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; border-width: medium; border-style: none; border-color: currentcolor; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="border-top-width: medium; border-top-style: none; border-top-color: currentcolor; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-right-width: medium; border-right-style: none; border-right-color: currentcolor; width: 1%; vertical-align: bottom;"&gt;


      &lt;span style="font-weight: bold;"&gt;2025&lt;/span&gt;
     &lt;/td&gt;&lt;td style="border-width: medium; border-style: none; border-color: currentcolor; text-align: center; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;

   &lt;tr style="vertical-align: top;"&gt;
    &lt;td&gt;&lt;i&gt;(in thousands, except
per share amounts)&lt;/i&gt;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;


    &lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;&lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Net  loss
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: bottom;"&gt;$&lt;/td&gt;


    &lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;(4,541&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;)&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;(3,014&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;)&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Deemed dividend attributable to Series J Convertible Preferred Stock
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: bottom; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;


    &lt;td style="text-align: right; width: 9%; vertical-align: bottom; border-bottom: 2px solid black;"&gt;2&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom; border-bottom: 2px solid black;"&gt;1&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Net  loss attributable to common shareholders
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: bottom;"&gt;$&lt;/td&gt;


    &lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;(4,539&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;)&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;(3,013&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;)&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="padding-left: 10px;"&gt;
     &lt;div&gt;
      Weighted average shares outstanding
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: bottom; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;


    &lt;td style="text-align: right; width: 9%; vertical-align: bottom; border-bottom: 2px solid black;"&gt;2,075&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom; border-bottom: 2px solid black;"&gt;104&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Basic and diluted  loss per share
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: bottom; border-bottom: 4px double black;"&gt;$&lt;/td&gt;


    &lt;td style="text-align: right; width: 9%; vertical-align: bottom; border-bottom: 4px double black;"&gt;(2.19&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 4px double transparent;"&gt;)&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 4px double black;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom; border-bottom: 4px double black;"&gt;(28.93&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 4px double transparent;"&gt;)&#160;&lt;/td&gt;
   &lt;/tr&gt;
  &lt;/table&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &lt;span style="font-style: italic;"&gt;Recently Issued Accounting Pronouncements: &lt;/span&gt;In November 2024, the FASB issued ASU 2024-03, Income
Statement: Reporting Comprehensive Income- Expense Disaggregation Disclosures,
which requires detailed information about specified categories of expenses
included in certain expense captions presented on the face of the income
statement, as well as disclosures about selling expenses. This ASU is effective
for fiscal years beginning after December 15, 2026 and for interim periods
within fiscal years beginning after December 15, 2027. Early adoption is permitted.
The amendments may be applied either (1) prospectively to financial statements
issued for reporting periods after the effective date of this ASU or (2)
retrospectively to all prior periods presented in the financial statements. The
Company is currently evaluating this guidance to determine the impact it may
have on its consolidated financial statements disclosures.&lt;/div&gt;&lt;div style="margin: 0in;"&gt;&#160;&lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &lt;span style="font-style: italic;"&gt;Subsequent Events:&lt;/span&gt; The Company evaluates events through the date the condensed consolidated financial statements are filed for events requiring adjustment to or disclosure in the condensed consolidated financial statements. See Note 11 &#x2013; Subsequent Events below for additional disclosures. &lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c0" id="ixv-2211">&lt;div style="font-size: 10pt; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif;"&gt; &lt;span style="font-style: italic;"&gt;Principles of Consolidation: &lt;/span&gt;The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. GAAP for interim financial information and do not include all disclosures required by GAAP for annual financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2025. The results of operations for the three months ended March 31, 2026 are not necessarily indicative of the results expected for the full year. &lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:BusinessCombinationsPolicy contextRef="c0" id="ixv-2215">&lt;div style="margin: 0in;"&gt;&lt;i style="mso-bidi-font-style:normal"&gt;Acquisitions: &lt;/i&gt;The Company evaluates
acquisitions pursuant to ASC 805, Business Combinations, to determine whether
the transaction should be accounted for as a business combination or an asset
acquisition.&lt;/div&gt;&lt;div style="margin: 0in;"&gt;For
asset acquisitions, the Company allocates the purchase price (including
transaction costs) to the individual assets acquired and liabilities assumed on
a relative fair value basis. Direct acquisition-related costs are capitalized
as part of the purchase price.&lt;/div&gt;&lt;div style="margin: 0in;"&gt;&lt;i&gt;Acquired
In-Process Research and Development Expenses:&lt;/i&gt;&lt;span style="font-size:12.0pt"&gt;
&lt;/span&gt;Acquired in-process research and development activities include payments
pursuant to the Company&#x2019;s asset acquisition. In-process research and
development that is acquired in a transaction that does not qualify as a
business combination under U.S. GAAP and that does not have an alternative
future use is recorded as Research and Development expense in the consolidated
statements of operations in the period in which it is acquired.&lt;span style="mso-spacerun:yes"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin: 0in;"&gt;The
Company expensed $757 thousand of acquired in-process research and development
related to the Rendiatech asset acquisition during the three months ended March
31, 2026, as it had no alternative future use.&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:InProcessResearchAndDevelopmentPolicy contextRef="c0" id="ixv-2223">&lt;div style="margin: 0in;"&gt;&lt;i&gt;Acquired
In-Process Research and Development Expenses:&lt;/i&gt;&lt;span style="font-size:12.0pt"&gt;
&lt;/span&gt;Acquired in-process research and development activities include payments
pursuant to the Company&#x2019;s asset acquisition. In-process research and
development that is acquired in a transaction that does not qualify as a
business combination under U.S. GAAP and that does not have an alternative
future use is recorded as Research and Development expense in the consolidated
statements of operations in the period in which it is acquired.&lt;span style="mso-spacerun:yes"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;</us-gaap:InProcessResearchAndDevelopmentPolicy>
    <nuwe:NoncashInProcessResearchAndDevelopmentfromRendiatechAcquisition contextRef="c0" decimals="-3" id="ixv-5665" unitRef="usd">757000</nuwe:NoncashInProcessResearchAndDevelopmentfromRendiatechAcquisition>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="c0" id="ixv-2232">&lt;div style="margin: 0in;"&gt;&lt;i style="mso-bidi-font-style:normal"&gt;Intangible Assets:&lt;/i&gt;&lt;span style="font-size:12.0pt"&gt; &lt;/span&gt;Intangible assets&lt;span style="mso-spacerun:yes"&gt;&#160; &lt;/span&gt;comprise non-competition agreements and
website development costs. Intangible assets with finite lives are amortized
over the period the assets are expected to contribute directly or indirectly to
future cash flows.&lt;/div&gt;&lt;div style="font-size: 10pt; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif;"&gt;
   Intangible assets are reviewed for impairment annually or more frequently if indicators of impairment exist.
  &lt;/div&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <nuwe:GoingConcernPolicyTextBlock contextRef="c0" id="ixv-2250">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &lt;span style="font-style: italic;"&gt;Going Concern:&lt;/span&gt;&lt;span style="font-weight: bold; font-style: italic;"&gt;&#160;&lt;/span&gt;The Company&#x2019;s condensed consolidated financial statements have been prepared assuming it will continue as a going concern. As of March 31, 2026, the Company had an accumulated deficit of $320.9 million and expects to continue incurring losses in the near term. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   To date, the Company has been funded primarily through equity financings. The Company believes its existing capital resources will be sufficient to support its operating plan into the second quarter of 2026. It will also continue to evaluate opportunities to raise additional capital through debt, equity, or a combination thereof to support growth initiatives and strengthen its balance sheet. While the Company is confident in its ability to fund operations and execute on its strategic plan, there can be no assurance that additional capital will be available on favorable terms, or at all, or that the Company will achieve profitability.
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   These conditions, including continued operating losses, negative cash flows from operations, an accumulated deficit of $320.9 million, and the need for additional capital to fund ongoing operations and growth initiatives (including the integration of the Rendiatech acquisition), raise substantial doubt about the Company&#x2019;s ability to continue as a going concern for at least twelve months from the date these financial statements are issued. While management&#x2019;s plans, including recent financing activities, cost discipline initiatives, and contingency measures, are intended to address these conditions, such plans do not alleviate the substantial doubt. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
  &lt;/div&gt;</nuwe:GoingConcernPolicyTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c2" decimals="-5" id="ixv-5666" unitRef="usd">-320900000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c0" id="ixv-2261">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &lt;span style="font-style: italic;"&gt;Segment Information&lt;/span&gt;: Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision-maker in deciding how to allocate resources and assess performance. The Company and the Company&#x2019;s chief operating decision-maker (the &#x201c;CODM&#x201d;), the chief executive officer, view the Company&#x2019;s operations and manages its business as a single operating segment. On March 31, 2026 and December 31, 2025, long-lived assets were located primarily in the United States. See Note 9 &#x2014; Segment Reporting for additional information. &lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c0" id="ixv-2265">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &lt;span style="font-style: italic;"&gt;Revenue Recognition: &lt;/span&gt;The Company recognizes revenue in accordance with Accounting Standards Codification, Topic 606, Revenue from Contracts with Customers, which the Company adopted effective January 1, 2018. Accordingly, the Company recognizes revenue when its customers obtain control of its products or services, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods and services. See Note 2 &#x2013; Revenue Recognition below for additional disclosures. For the three months ended March 31, 2026, three customer represented 14%, 11%, and 10% of net sales. For the three months ended March 31, 2025, one customer represented 14% of net sales. &lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <nuwe:NumberOfMajorCustomers
      contextRef="c39"
      decimals="0"
      id="ixv-5667"
      unitRef="Customer">3</nuwe:NumberOfMajorCustomers>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c40" decimals="2" id="ixv-5668" unitRef="pure">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c41" decimals="2" id="ixv-5669" unitRef="pure">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c42" decimals="2" id="ixv-5670" unitRef="pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <nuwe:NumberOfMajorCustomers
      contextRef="c43"
      decimals="0"
      id="ixv-5671"
      unitRef="Customer">1</nuwe:NumberOfMajorCustomers>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c44" decimals="2" id="ixv-5672" unitRef="pure">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c0" id="ixv-2269">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; Inventories consisted of the following: &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;
   &lt;tr style="height: 0px; font-size: 0px;"&gt;
    &lt;td style="width: 76%;"&gt;&#160;&lt;/td&gt;


    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;



    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;

   &lt;/tr&gt;

   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: bottom;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      &lt;span style="font-style: italic;"&gt;(in thousands)&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align: bottom; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; text-align: center;"&gt;
     &lt;div&gt;
      &lt;span style="font-weight: bold;"&gt;March 31,&lt;br/&gt; 2026&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;&lt;td colspan="1" style="vertical-align: bottom; border-width: medium; border-style: none; border-color: currentcolor; white-space: nowrap; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;


    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align: bottom; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; width: 1%; text-align: center;"&gt;
     &lt;div&gt;
      &lt;span style="font-weight: bold;"&gt;December 31,&lt;br/&gt; 2025&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;&lt;td colspan="1" style="vertical-align: bottom; border-width: medium; border-style: none; border-color: currentcolor; white-space: nowrap; width: 1%;"&gt;&#160;&lt;/td&gt;

   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="text-align: left;"&gt;Finished Goods&lt;/td&gt;


    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%;"&gt;285&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;



    &lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%;"&gt;445&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;

   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Work in Process
     &lt;/div&gt;
    &lt;/td&gt;


    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%;"&gt;138&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;



    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%;"&gt;88&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;

   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Raw Materials
     &lt;/div&gt;
    &lt;/td&gt;


    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%;"&gt;1,449&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;



    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%;"&gt;1,457&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;

   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Inventory Reserves
     &lt;/div&gt;
    &lt;/td&gt;


    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid black;"&gt;(93&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid transparent;"&gt;)&#160;&lt;/td&gt;



    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid black;"&gt;(80&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid transparent;"&gt;)&#160;&lt;/td&gt;

   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="padding-left: 10px;"&gt;
     &lt;div&gt;
      Total
     &lt;/div&gt;
    &lt;/td&gt;


    &lt;td style="vertical-align: bottom; text-decoration: underline; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 4px double black;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double black;"&gt;1,779&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 4px double transparent;"&gt;&#160;&lt;/td&gt;



    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 4px double black;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double black;"&gt;1,910&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 4px double transparent;"&gt;&#160;&lt;/td&gt;

   &lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryPolicyTextBlock contextRef="c0" id="ixv-2270">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; Inventories consisted of the following: &lt;/div&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;
   &lt;tr style="height: 0px; font-size: 0px;"&gt;
    &lt;td style="width: 76%;"&gt;&#160;&lt;/td&gt;


    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;



    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;

   &lt;/tr&gt;

   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: bottom;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      &lt;span style="font-style: italic;"&gt;(in thousands)&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;

    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align: bottom; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; text-align: center;"&gt;
     &lt;div&gt;
      &lt;span style="font-weight: bold;"&gt;March 31,&lt;br/&gt; 2026&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;&lt;td colspan="1" style="vertical-align: bottom; border-width: medium; border-style: none; border-color: currentcolor; white-space: nowrap; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;


    &lt;td colspan="1" style="vertical-align: bottom; white-space: nowrap; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align: bottom; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; width: 1%; text-align: center;"&gt;
     &lt;div&gt;
      &lt;span style="font-weight: bold;"&gt;December 31,&lt;br/&gt; 2025&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;&lt;td colspan="1" style="vertical-align: bottom; border-width: medium; border-style: none; border-color: currentcolor; white-space: nowrap; width: 1%;"&gt;&#160;&lt;/td&gt;

   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="text-align: left;"&gt;Finished Goods&lt;/td&gt;


    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%;"&gt;285&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;



    &lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%;"&gt;445&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;

   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Work in Process
     &lt;/div&gt;
    &lt;/td&gt;


    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%;"&gt;138&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;



    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%;"&gt;88&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;

   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Raw Materials
     &lt;/div&gt;
    &lt;/td&gt;


    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%;"&gt;1,449&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;



    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%;"&gt;1,457&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;

   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Inventory Reserves
     &lt;/div&gt;
    &lt;/td&gt;


    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid black;"&gt;(93&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid transparent;"&gt;)&#160;&lt;/td&gt;



    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid black;"&gt;(80&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 2px solid transparent;"&gt;)&#160;&lt;/td&gt;

   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="padding-left: 10px;"&gt;
     &lt;div&gt;
      Total
     &lt;/div&gt;
    &lt;/td&gt;


    &lt;td style="vertical-align: bottom; text-decoration: underline; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 4px double black;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double black;"&gt;1,779&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 4px double transparent;"&gt;&#160;&lt;/td&gt;



    &lt;td style="vertical-align: bottom; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 4px double black;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double black;"&gt;1,910&lt;/td&gt;&lt;td style="vertical-align: bottom; text-align: left; width: 1%; border-bottom: 4px double transparent;"&gt;&#160;&lt;/td&gt;

   &lt;/tr&gt;
  &lt;/table&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryFinishedGoods contextRef="c2" decimals="-3" id="ixv-5673" unitRef="usd">285000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="c3" decimals="-3" id="ixv-5674" unitRef="usd">445000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryWorkInProcess contextRef="c2" decimals="-3" id="ixv-5675" unitRef="usd">138000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="c3" decimals="-3" id="ixv-5676" unitRef="usd">88000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryRawMaterials contextRef="c2" decimals="-3" id="ixv-5677" unitRef="usd">1449000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="c3" decimals="-3" id="ixv-5678" unitRef="usd">1457000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryValuationReserves contextRef="c2" decimals="-3" id="ixv-5679" unitRef="usd">93000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves contextRef="c3" decimals="-3" id="ixv-5680" unitRef="usd">80000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryNet contextRef="c2" decimals="-3" id="ixv-5681" unitRef="usd">1779000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c3" decimals="-3" id="ixv-5682" unitRef="usd">1910000</us-gaap:InventoryNet>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c0" id="ixv-2356">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &lt;span style="font-style: italic;"&gt;Loss per Share:&lt;/span&gt;&#160;Basic loss per share is computed based on the net loss for each period divided by the weighted average number of common shares outstanding. See Note 3 &#x2013; Stockholders&#x2019; Equity below for additional disclosures. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   Diluted earnings per share is computed based on the net loss allocable to common stockholders for each period divided by the weighted average number of common shares outstanding, increased by the number of additional shares that would have been outstanding had the potentially dilutive common shares been issued, and reduced by the number of shares the Company could have repurchased from the proceeds from issuance of the potentially dilutive shares. Potentially dilutive shares of common stock include shares underlying outstanding convertible preferred stock, warrants, stock options and other stock-based awards granted under stock-based compensation plans.
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; The following table sets forth the potential shares of common stock that are not included in the calculation of diluted net loss per share because to do so would be anti-dilutive as of the end of each period presented: &lt;/div&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;
 &lt;tr style="height: 0px; font-size: 0px;"&gt;
  &lt;td style="height: 1pt; width: 76%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; width: 9%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; width: 9%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:1;height:1.0pt"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td colspan="6" style="width: 1%; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); text-align: center;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;&lt;b style="mso-bidi-font-weight:   normal"&gt;March 31&lt;/b&gt;&lt;/div&gt;
      &lt;/td&gt;
  &lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:2;height:1.0pt"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%; text-align: center;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;&lt;b style="mso-bidi-font-weight:   normal"&gt;2026&lt;/b&gt;&lt;/div&gt;
  &lt;/td&gt;&lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%; text-align: center;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;&lt;b style="mso-bidi-font-weight:   normal"&gt;2025&lt;/b&gt;&lt;/div&gt;
  &lt;/td&gt;&lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="height: 1pt; background-color: rgb(204, 238, 255);"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;Stock options&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%;" valign="top"&gt;34,446&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%;" valign="top"&gt;81&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:4;height:1.0pt"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;Warrants to purchase common
  stock&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%;" valign="top"&gt;4,815,296&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%;" valign="top"&gt;126,787&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="height: 1pt; background-color: rgb(204, 238, 255);"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;Series F convertible preferred
  stock&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%;" valign="top"&gt;10,719&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%;" valign="top"&gt;1,642&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;&lt;tr&gt;
  &lt;td valign="top"&gt;Series F-1
convertible preferred stock&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: right; width: 9%;" valign="top"&gt;13,498&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: right; width: 9%;" valign="top"&gt;&#x2014;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;

 &lt;tr style="height: 1pt; background-color: rgb(204, 238, 255);"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;Series J convertible preferred
  stock&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-bottom: 2px solid black;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%; border-bottom: 2px solid black;" valign="top"&gt;87&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-bottom: 2px solid black;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%; border-bottom: 2px solid black;" valign="top"&gt;2&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="height: 1pt;"&gt;
  &lt;td style="height: 1pt; padding-left: 10px;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;Total&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-width: medium medium 4px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%; border-width: medium medium 4px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" valign="top"&gt;4,874,046&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-width: medium medium 4px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%; border-width: medium medium 4px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" valign="top"&gt;128,512&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
&lt;/table&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; The following table reconciles reported net loss with reported net loss per share for each of the three months ended: &lt;/div&gt;&lt;table cellpadding="0" style="font-size: 10pt; border-collapse: collapse; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;
   &lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td style="width: 76%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;


    &lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="font-size: 0px;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="6" style="width: 1%; vertical-align: bottom; text-align: center; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; border-width: medium medium 2px; border-style: none none solid;"&gt;



      &lt;span style="font-weight: bold;"&gt;Three months ended&lt;br/&gt;

      March 31&lt;/span&gt;
         &lt;/td&gt;

    &lt;td style="border-width: medium; border-style: none; border-color: currentcolor; text-align: center; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="font-size: 0px;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="width: 1%; vertical-align: bottom; text-align: center; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;


      &lt;span style="font-weight: bold;"&gt;2026&lt;/span&gt;
     &lt;/td&gt;


    &lt;td style="border-width: medium; border-style: none; border-color: currentcolor; text-align: center; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; border-width: medium; border-style: none; border-color: currentcolor; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="border-top-width: medium; border-top-style: none; border-top-color: currentcolor; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-right-width: medium; border-right-style: none; border-right-color: currentcolor; width: 1%; vertical-align: bottom;"&gt;


      &lt;span style="font-weight: bold;"&gt;2025&lt;/span&gt;
     &lt;/td&gt;&lt;td style="border-width: medium; border-style: none; border-color: currentcolor; text-align: center; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;

   &lt;tr style="vertical-align: top;"&gt;
    &lt;td&gt;&lt;i&gt;(in thousands, except
per share amounts)&lt;/i&gt;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;


    &lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;&lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Net  loss
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: bottom;"&gt;$&lt;/td&gt;


    &lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;(4,541&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;)&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;(3,014&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;)&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Deemed dividend attributable to Series J Convertible Preferred Stock
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: bottom; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;


    &lt;td style="text-align: right; width: 9%; vertical-align: bottom; border-bottom: 2px solid black;"&gt;2&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom; border-bottom: 2px solid black;"&gt;1&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Net  loss attributable to common shareholders
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: bottom;"&gt;$&lt;/td&gt;


    &lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;(4,539&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;)&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;(3,013&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;)&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="padding-left: 10px;"&gt;
     &lt;div&gt;
      Weighted average shares outstanding
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: bottom; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;


    &lt;td style="text-align: right; width: 9%; vertical-align: bottom; border-bottom: 2px solid black;"&gt;2,075&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom; border-bottom: 2px solid black;"&gt;104&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Basic and diluted  loss per share
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: bottom; border-bottom: 4px double black;"&gt;$&lt;/td&gt;


    &lt;td style="text-align: right; width: 9%; vertical-align: bottom; border-bottom: 4px double black;"&gt;(2.19&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 4px double transparent;"&gt;)&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 4px double black;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom; border-bottom: 4px double black;"&gt;(28.93&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 4px double transparent;"&gt;)&#160;&lt;/td&gt;
   &lt;/tr&gt;
  &lt;/table&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c0" id="ixv-2363">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; The following table sets forth the potential shares of common stock that are not included in the calculation of diluted net loss per share because to do so would be anti-dilutive as of the end of each period presented: &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;
 &lt;tr style="height: 0px; font-size: 0px;"&gt;
  &lt;td style="height: 1pt; width: 76%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; width: 9%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; width: 9%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:1;height:1.0pt"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td colspan="6" style="width: 1%; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); text-align: center;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;&lt;b style="mso-bidi-font-weight:   normal"&gt;March 31&lt;/b&gt;&lt;/div&gt;
      &lt;/td&gt;
  &lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:2;height:1.0pt"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%; text-align: center;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;&lt;b style="mso-bidi-font-weight:   normal"&gt;2026&lt;/b&gt;&lt;/div&gt;
  &lt;/td&gt;&lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%; text-align: center;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;&lt;b style="mso-bidi-font-weight:   normal"&gt;2025&lt;/b&gt;&lt;/div&gt;
  &lt;/td&gt;&lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="height: 1pt; background-color: rgb(204, 238, 255);"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;Stock options&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%;" valign="top"&gt;34,446&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%;" valign="top"&gt;81&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:4;height:1.0pt"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;Warrants to purchase common
  stock&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%;" valign="top"&gt;4,815,296&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%;" valign="top"&gt;126,787&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="height: 1pt; background-color: rgb(204, 238, 255);"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;Series F convertible preferred
  stock&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%;" valign="top"&gt;10,719&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%;" valign="top"&gt;1,642&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;&lt;tr&gt;
  &lt;td valign="top"&gt;Series F-1
convertible preferred stock&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: right; width: 9%;" valign="top"&gt;13,498&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: right; width: 9%;" valign="top"&gt;&#x2014;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;

 &lt;tr style="height: 1pt; background-color: rgb(204, 238, 255);"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;Series J convertible preferred
  stock&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-bottom: 2px solid black;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%; border-bottom: 2px solid black;" valign="top"&gt;87&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-bottom: 2px solid black;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%; border-bottom: 2px solid black;" valign="top"&gt;2&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="height: 1pt;"&gt;
  &lt;td style="height: 1pt; padding-left: 10px;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;Total&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-width: medium medium 4px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%; border-width: medium medium 4px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" valign="top"&gt;4,874,046&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-width: medium medium 4px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; text-align: right; width: 9%; border-width: medium medium 4px; border-style: none none double; border-color: currentcolor currentcolor rgb(0, 0, 0);" valign="top"&gt;128,512&lt;/td&gt;&lt;td style="margin: 0in; text-align: left; width: 1%; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c45"
      decimals="0"
      id="ixv-5683"
      unitRef="shares">34446</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c46"
      decimals="0"
      id="ixv-5684"
      unitRef="shares">81</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c47"
      decimals="0"
      id="ixv-5685"
      unitRef="shares">4815296</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c48"
      decimals="0"
      id="ixv-5686"
      unitRef="shares">126787</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c49"
      decimals="0"
      id="ixv-5687"
      unitRef="shares">10719</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c50"
      decimals="0"
      id="ixv-5688"
      unitRef="shares">1642</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c51"
      decimals="0"
      id="ixv-5689"
      unitRef="shares">13498</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c52"
      decimals="0"
      id="ixv-5690"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c53"
      decimals="0"
      id="ixv-5691"
      unitRef="shares">87</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c54"
      decimals="0"
      id="ixv-5692"
      unitRef="shares">2</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c0" decimals="0" id="ixv-5693" unitRef="shares">4874046</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c12"
      decimals="0"
      id="ixv-5694"
      unitRef="shares">128512</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c0" id="ixv-2472">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; The following table reconciles reported net loss with reported net loss per share for each of the three months ended: &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;table cellpadding="0" style="font-size: 10pt; border-collapse: collapse; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;
   &lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td style="width: 76%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0px; font-size: 0px;"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;


    &lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="font-size: 0px;"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="1" style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="6" style="width: 1%; vertical-align: bottom; text-align: center; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; border-width: medium medium 2px; border-style: none none solid;"&gt;



      &lt;span style="font-weight: bold;"&gt;Three months ended&lt;br/&gt;

      March 31&lt;/span&gt;
         &lt;/td&gt;

    &lt;td style="border-width: medium; border-style: none; border-color: currentcolor; text-align: center; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="font-size: 0px;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="width: 1%; vertical-align: bottom; text-align: center; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);"&gt;


      &lt;span style="font-weight: bold;"&gt;2026&lt;/span&gt;
     &lt;/td&gt;


    &lt;td style="border-width: medium; border-style: none; border-color: currentcolor; text-align: center; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; border-width: medium; border-style: none; border-color: currentcolor; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="border-top-width: medium; border-top-style: none; border-top-color: currentcolor; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-right-width: medium; border-right-style: none; border-right-color: currentcolor; width: 1%; vertical-align: bottom;"&gt;


      &lt;span style="font-weight: bold;"&gt;2025&lt;/span&gt;
     &lt;/td&gt;&lt;td style="border-width: medium; border-style: none; border-color: currentcolor; text-align: center; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;

   &lt;tr style="vertical-align: top;"&gt;
    &lt;td&gt;&lt;i&gt;(in thousands, except
per share amounts)&lt;/i&gt;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;


    &lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;&lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Net  loss
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: bottom;"&gt;$&lt;/td&gt;


    &lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;(4,541&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;)&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;(3,014&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;)&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Deemed dividend attributable to Series J Convertible Preferred Stock
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: bottom; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;


    &lt;td style="text-align: right; width: 9%; vertical-align: bottom; border-bottom: 2px solid black;"&gt;2&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom; border-bottom: 2px solid black;"&gt;1&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Net  loss attributable to common shareholders
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: bottom;"&gt;$&lt;/td&gt;


    &lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;(4,539&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;)&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;(3,013&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;)&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="padding-left: 10px;"&gt;
     &lt;div&gt;
      Weighted average shares outstanding
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: bottom; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;


    &lt;td style="text-align: right; width: 9%; vertical-align: bottom; border-bottom: 2px solid black;"&gt;2,075&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; border-width: medium; border-style: none; border-color: currentcolor; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom; border-bottom: 2px solid black;"&gt;104&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Basic and diluted  loss per share
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: bottom; border-bottom: 4px double black;"&gt;$&lt;/td&gt;


    &lt;td style="text-align: right; width: 9%; vertical-align: bottom; border-bottom: 4px double black;"&gt;(2.19&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 4px double transparent;"&gt;)&#160;&lt;/td&gt;
    &lt;td style="text-align: right; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 4px double black;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom; border-bottom: 4px double black;"&gt;(28.93&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom; border-bottom: 4px double transparent;"&gt;)&#160;&lt;/td&gt;
   &lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-5695" unitRef="usd">-4541000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c12" decimals="-3" id="ixv-5696" unitRef="usd">-3014000</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments contextRef="c0" decimals="-3" id="ixv-5697" unitRef="usd">-2000</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments contextRef="c12" decimals="-3" id="ixv-5698" unitRef="usd">-1000</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c0" decimals="-3" id="ixv-5699" unitRef="usd">-4539000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c12" decimals="-3" id="ixv-5700" unitRef="usd">-3013000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c0"
      decimals="-3"
      id="ixv-5701"
      unitRef="shares">2075000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c0"
      decimals="-3"
      id="ixv-5702"
      unitRef="shares">2075000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c12"
      decimals="-3"
      id="ixv-5703"
      unitRef="shares">104000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c12"
      decimals="-3"
      id="ixv-5704"
      unitRef="shares">104000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="c0"
      decimals="2"
      id="ixv-5705"
      unitRef="usdPershares">-2.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c0"
      decimals="2"
      id="ixv-5706"
      unitRef="usdPershares">-2.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c12"
      decimals="2"
      id="ixv-5707"
      unitRef="usdPershares">-28.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c12"
      decimals="2"
      id="ixv-5708"
      unitRef="usdPershares">-28.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c0" id="ixv-2582">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &lt;span style="font-style: italic;"&gt;Recently Issued Accounting Pronouncements: &lt;/span&gt;In November 2024, the FASB issued ASU 2024-03, Income
Statement: Reporting Comprehensive Income- Expense Disaggregation Disclosures,
which requires detailed information about specified categories of expenses
included in certain expense captions presented on the face of the income
statement, as well as disclosures about selling expenses. This ASU is effective
for fiscal years beginning after December 15, 2026 and for interim periods
within fiscal years beginning after December 15, 2027. Early adoption is permitted.
The amendments may be applied either (1) prospectively to financial statements
issued for reporting periods after the effective date of this ASU or (2)
retrospectively to all prior periods presented in the financial statements. The
Company is currently evaluating this guidance to determine the impact it may
have on its consolidated financial statements disclosures.&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SubsequentEventsPolicyPolicyTextBlock contextRef="c0" id="ixv-2586">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &lt;span style="font-style: italic;"&gt;Subsequent Events:&lt;/span&gt; The Company evaluates events through the date the condensed consolidated financial statements are filed for events requiring adjustment to or disclosure in the condensed consolidated financial statements. See Note 11 &#x2013; Subsequent Events below for additional disclosures. &lt;/div&gt;</us-gaap:SubsequentEventsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c0" id="ixv-2590">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   &lt;span style="font-weight: bold;"&gt;Note 2 &#x2013; Revenue Recognition&lt;/span&gt;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers, which was adopted effective January 1, 2018. Revenue is recognized when control of promised goods or services is transferred to the customer in an amount that reflects the consideration expected to be received. The majority of contracts have a single performance obligation and are short-term in nature. Revenue from extended service plans (less than 1% of net sales) is recognized over time and included in deferred revenue (classified in other current liabilities). See Note 1 to the consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2025, for a full description of our revenue recognition policy. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &lt;span style="font-style: italic;"&gt;International Exit:&lt;/span&gt;&#160;On August 7, 2025, the Company announced its decision to exit substantially all its international operations in order to focus exclusively on the U.S. market&#x2014;where the Company is seeing the strongest growth and clinical demand. With expanding traction in U.S. cardiac surgery and pediatric programs, and a rising opportunity in the hospital-based outpatient space, the Company is streamlining to prioritize investment in markets where it can have the most immediate and long-term impact. As of March 31, 2026, the Company&#x2019;s remaining accrued contractual exit fees and product repurchase obligations were $49 thousand. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &lt;span style="font-style: italic;"&gt;Customer Concentration:&lt;/span&gt; For the three months ended March 31, 2026, three customers represented 14%, 11%, and 10% of net sales. For the three months ended March 31, 2025, one customer represented 14% of net sales. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   &lt;span style="font-style: italic;"&gt;Product Returns and Other:&lt;/span&gt;&#160;The Company estimates product returns based on historical data and industry information. Returns have been minimal to date, and no material variable consideration adjustment was required in the current period. Shipping and handling costs are included in cost of goods sold, and sales taxes are excluded from revenue.
  &lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c55" decimals="2" id="ixv-5709" unitRef="pure">0.01</us-gaap:ConcentrationRiskPercentage1>
    <nuwe:ContractualExitFeesAndProductRepurchaseObligations contextRef="c2" decimals="-3" id="ixv-5710" unitRef="usd">49000</nuwe:ContractualExitFeesAndProductRepurchaseObligations>
    <nuwe:NumberOfMajorCustomers
      contextRef="c39"
      decimals="0"
      id="ixv-5711"
      unitRef="Customer">3</nuwe:NumberOfMajorCustomers>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c40" decimals="2" id="ixv-5712" unitRef="pure">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c41" decimals="2" id="ixv-5713" unitRef="pure">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c42" decimals="2" id="ixv-5714" unitRef="pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <nuwe:NumberOfMajorCustomers
      contextRef="c43"
      decimals="0"
      id="ixv-5715"
      unitRef="Customer">1</nuwe:NumberOfMajorCustomers>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c44" decimals="2" id="ixv-5716" unitRef="pure">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c0" id="ixv-2612">&lt;div style="font-weight: bold; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   Note 3 &#x2013; Stockholders&#x2019; Equity
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &lt;span style="font-style: italic;"&gt;Series F Convertible Preferred Stock: &lt;/span&gt;As of March 31, 2026 and December 31, 2025, 27 shares and 127 shares of Series F convertible preferred stock remained outstanding, respectively (par value $0.0001 per share; authorized 18,000 shares). The conversion price was last adjusted to $397.00 following the 2025 reverse stock split. See Note 4 in our Annual Report on Form 10-K for the year ended December 31, 2025, for a description of the terms, anti-dilution provisions, and historical issuances. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &lt;span style="font-style: italic;"&gt;Series F-1 Convertible Preferred Stock: &lt;/span&gt;As of March 31, 2026, 34 shares of Series F-1 convertible preferred stock remained outstanding. These shares were issued in exchange for Series F shares held by our CEO in June 2025. See Note 4 in our Annual Report on Form 10-K for the year ended December 31, 2025, for further details. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &lt;span style="font-style: italic;"&gt;Common Stock and Warrants: &lt;/span&gt;During the three months ended March 31, 2026, the Company completed a private placement and related warrant inducement transaction that raised aggregate gross proceeds of approximately $5.0 million before placement agent fees and offering expenses. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &lt;span style="font-style: italic;"&gt;January 2026 Private Placement and Warrant Inducement Offer(&#x201c;January 2026 Transaction&#x201d;): &lt;/span&gt;On January 29, 2026, the Company entered into a securities purchase agreement with Armistice Capital Master Fund Ltd. (&#x201c;Armistice&#x201d;) for a private placement (the &#x201c;Private Placement&#x201d;) in which it issued (i) 994,537 pre-funded common stock purchase warrants (&#x201c;Pre-Funded Warrants&#x201d;) to purchase up to 994,537 shares of common stock at an exercise price of $0.0001 per share and (ii) 1,989,074 common stock purchase warrants (&#x201c;Private Placement Common Warrants&#x201d;) to purchase up to 1,989,074 shares of common stock at an exercise price of $2.84 per share, for a combined purchase price of $3.09 per Pre-Funded Warrant and accompanying warrants. The transaction generated approximately $3.1 million in gross proceeds. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; Simultaneously, the Company entered into a warrant inducement offer letter with Armistice (the &#x201c;Inducement Offer&#x201d;) pursuant to which Armistice exercised its remaining outstanding Series A and Series B warrants (issued June 2025) and Series I and Series II warrants (issued November 2024) (collectively, the &#x201c;Existing Warrants&#x201d;) to purchase 623,585 shares of common stock at a reduced exercise price of $2.84 per share. In connection with the exercise, the Company issued new common stock purchase warrants (&#x201c;Inducement Warrants&#x201d;) to purchase up to 1,247,170 shares of common stock (200% of the shares issued upon exercise of the Existing Warrants) at an exercise price of $2.84 per share. The Inducement Offer generated approximately $2.0 million in gross proceeds. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; As compensation to the exclusive placement agent, Ladenburg Thalmann &amp;amp; Co. Inc., the Company issued warrants to the placement agent (the &#x201c;Agent Warrants&#x201d;) to purchase up to 48,544 shares of common stock at an exercise price of $5.0985 per share. The Agent Warrants have substantially the same terms as the Private Placement Common Warrants and Inducement Warrants and expire on January 29, 2031. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; All warrants issued in the January 2026 transactions (Pre-Funded Warrants, Private Placement Common Warrants, Inducement Warrants, and Agent Warrants) were determined to be freestanding financial instruments that qualify for equity classification under ASC 480 and ASC 815-40. Accordingly, they are recorded in stockholders&#x2019; equity. The Company allocated the net proceeds from the Private Placement on a relative fair value basis using the Black-Scholes option pricing model and recorded all direct and incremental issuance costs (including the 8.0% cash placement agent fee, expense reimbursement, and the fair value of the Agent Warrants) as a reduction of additional paid-in capital. The modification of the Existing Warrants was accounted for as an equity transaction, with any incremental fair value recognized as an equity issuance cost. No derivative liabilities were recorded, and no further remeasurement is required. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   &lt;span style="font-style: italic;"&gt;Key Black-Scholes valuation inputs (January 29, 2026):&lt;/span&gt;
  &lt;/div&gt;&lt;div style="text-indent: -18pt; padding-left: 36pt;"&gt; &lt;div style="float: left; width: 18pt; white-space: nowrap; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &#x25cf; &lt;/div&gt; &lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; Current stock price: $4.19 &lt;/div&gt; &lt;/div&gt;&lt;div style="text-indent: -18pt; padding-left: 36pt;"&gt; &lt;div style="float: left; width: 18pt; white-space: nowrap; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &#x25cf; &lt;/div&gt; &lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; Expected volatility: 148.1% &lt;/div&gt; &lt;/div&gt;&lt;div style="text-indent: -18pt; padding-left: 36pt;"&gt; &lt;div style="float: left; width: 18pt; white-space: nowrap; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &#x25cf; &lt;/div&gt; &lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; Expected term: 5.0 years &lt;/div&gt; &lt;/div&gt;&lt;div style="text-indent: -18pt; padding-left: 36pt;"&gt; &lt;div style="float: left; width: 18pt; white-space: nowrap; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &#x25cf; &lt;/div&gt; &lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; Risk-free interest rate: 3.80% &lt;/div&gt; &lt;/div&gt;&lt;div style="text-indent: -18pt; padding-left: 36pt;"&gt; &lt;div style="float: left; width: 18pt; white-space: nowrap; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &#x25cf; &lt;/div&gt; &lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; Expected dividend yield: 0% &lt;/div&gt; &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; The following table summarizes the warrants issued in the January 2026 transactions that remain outstanding as of March 31, 2026: &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;table cellpadding="0" style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt; width: 100%; border-spacing: 0px;"&gt;
   &lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td style="width: 37%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 17%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: bottom;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      &lt;span style="font-style: italic; text-decoration: underline;"&gt;Warrant Type&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; white-space: nowrap;"&gt;
     &lt;div&gt;
      &lt;span style="font-style: italic; text-decoration: underline;"&gt;Shares Underlying&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;&lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;
     &lt;div&gt;
      &lt;span style="font-style: italic; text-decoration: underline;"&gt;Exercise Price&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;&lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom;"&gt;
     &lt;div&gt;
      &lt;span style="font-style: italic; text-decoration: underline;"&gt;Fair Value&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom;"&gt;
     &lt;div&gt;
      &lt;span style="font-style: italic; text-decoration: underline;"&gt;Expiration Date&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: bottom;"&gt;
     &lt;div&gt;
      &lt;span style="font-style: italic; text-decoration: underline;"&gt;Status&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Pre-Funded Warrants
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%; vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;819,296&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;0.0001&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;4.19&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div&gt;
      Upon full exercise
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div&gt;
      Outstanding
     &lt;/div&gt;
    &lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Private Placement Common Warrants
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;1,989,074&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;2.84&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;3.887&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt; &lt;div&gt; January 30, 2031 &lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div&gt;
      Outstanding
     &lt;/div&gt;
    &lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Inducement Warrants
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;1,247,170&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;2.84&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;3.887&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt; &lt;div&gt; &lt;span style="-sec-ix-hidden: hidden-fact-2"&gt;5 years from resale registration effective date&lt;/span&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div&gt;
      Outstanding
     &lt;/div&gt;
    &lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Agent Warrants
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;48,544&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;5.0985&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;3.779&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt; &lt;div&gt; January 29, 2031 &lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div&gt;
      Outstanding
     &lt;/div&gt;
    &lt;/td&gt;
   &lt;/tr&gt;
  &lt;/table&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; Total shares potentially issuable upon exercise of January 2026 warrants:&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;4,104,084 (subject to applicable beneficial ownership limitations). The shares underlying these warrants have been registered for resale. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; In addition to the January 2026 activity, as of March 31, 2026, 6,268 Series B warrants remained unexercised with a fair value of approximately $6,583 (classified as warrant liabilities). See Note 5 &#x2013; Fair Value of Financial Instruments for additional warrant valuation details. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &lt;span style="font-style: italic;"&gt;Issuance of Common Stock and Stock Options in Connection with Rendiatech Acquisition: &lt;/span&gt;On March 17, 2026, the Company completed its asset acquisition of Rendiatech, Inc. (&#x201c;Rendiatech&#x201d;), an Israeli corporation formed to acquire certain assets of RenalSense Ltd. following its bankruptcy. As partial consideration for the acquisition, the Company issued 150,000 shares of its common stock to the sellers. These shares were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and were recorded at fair value based on the closing price of the Company&#x2019;s common stock on the acquisition date. The issuance is reflected in the condensed consolidated statements of stockholders&#x2019; equity as an increase in common stock issued and outstanding and additional paid-in capital. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; In addition, as part of the consideration, the Company granted stock options to purchase up to 30,000 shares of common stock to certain individuals associated with the sellers, with terms set forth in separate option agreements consistent with the Company&#x2019;s 2021 Inducement Plan (or other applicable equity plan). These options are subject to vesting conditions as outlined in the Securities Purchase Agreement and will be accounted for as stock-based compensation expense over the respective service periods. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; The equity securities issued in connection with the Rendiatech asset acquisition are subject to a six-month lock-up period from the closing date, during which the recipients may not offer, sell, or otherwise dispose of such securities, subject to certain customary exceptions. See Note 10 &#x2013; Asset Acquisitions for additional information regarding the acquisition, including the total consideration transferred and the preliminary purchase price allocation. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &lt;span style="font-style: italic;"&gt;At-The-Market Offering: &lt;/span&gt;We maintain an ATM agreement with Ladenburg Thalmann &amp;amp; Co. Inc. (entered September 3, 2025), under which we may sell common stock from time to time. As of March 31, 2026, we had sold 768,535 shares for net proceeds of approximately $2.9 million. No shares were sold under the ATM during the three months ended March 31, 2026. See Note 4 in our Annual Report on Form 10-K for the year ended December 31, 2025, for a description of the agreement terms. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &lt;span style="font-style: italic;"&gt;Reverse Stock Split: &lt;/span&gt;All share and per-share amounts have been retroactively adjusted to reflect the 2025 &lt;span style="-sec-ix-hidden: hidden-fact-3"&gt;one-for-42&lt;/span&gt; reverse stock split effective July 3, 2025. See Note 4 in our Annual Report on Form 10-K for the year ended December 31, 2025, for details. &lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c8"
      decimals="INF"
      id="ixv-5717"
      unitRef="shares">27</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c9"
      decimals="INF"
      id="ixv-5718"
      unitRef="shares">127</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c8"
      decimals="INF"
      id="ixv-5719"
      unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c9"
      decimals="INF"
      id="ixv-5720"
      unitRef="usdPershares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c8"
      decimals="INF"
      id="ixv-5721"
      unitRef="shares">18000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c9"
      decimals="INF"
      id="ixv-5722"
      unitRef="shares">18000</us-gaap:PreferredStockSharesAuthorized>
    <nuwe:ConversionOfStockSharesConversionPrice
      contextRef="c8"
      decimals="INF"
      id="ixv-5723"
      unitRef="usdPershares">397</nuwe:ConversionOfStockSharesConversionPrice>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c10"
      decimals="INF"
      id="ixv-5724"
      unitRef="shares">34</us-gaap:PreferredStockSharesOutstanding>
    <nuwe:GrossProceedsFromOfferingBeforeDeductingThePlacementAgentFeesAndOtherOfferingExpenses contextRef="c56" decimals="-5" id="ixv-5725" unitRef="usd">5000000</nuwe:GrossProceedsFromOfferingBeforeDeductingThePlacementAgentFeesAndOtherOfferingExpenses>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c57"
      decimals="INF"
      id="ixv-5726"
      unitRef="shares">994537</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c58"
      decimals="INF"
      id="ixv-5727"
      unitRef="shares">994537</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c58"
      decimals="4"
      id="ixv-5728"
      unitRef="usdPershares">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c59"
      decimals="INF"
      id="ixv-5729"
      unitRef="shares">1989074</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c60"
      decimals="INF"
      id="ixv-5730"
      unitRef="shares">1989074</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c61"
      decimals="2"
      id="ixv-5731"
      unitRef="usdPershares">2.84</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c62"
      decimals="2"
      id="ixv-5732"
      unitRef="usdPershares">3.09</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c63" decimals="-5" id="ixv-5733" unitRef="usd">3100000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c64"
      decimals="INF"
      id="ixv-5734"
      unitRef="shares">623585</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c64"
      decimals="2"
      id="ixv-5735"
      unitRef="usdPershares">2.84</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c65"
      decimals="INF"
      id="ixv-5736"
      unitRef="shares">1247170</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <nuwe:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsPercentageEqualToCommonStock
      contextRef="c66"
      decimals="INF"
      id="ixv-5737"
      unitRef="pure">2</nuwe:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsPercentageEqualToCommonStock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c66"
      decimals="2"
      id="ixv-5738"
      unitRef="usdPershares">2.84</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c67" decimals="-5" id="ixv-5739" unitRef="usd">2000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c68"
      decimals="INF"
      id="ixv-5740"
      unitRef="shares">48544</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c68"
      decimals="INF"
      id="ixv-5741"
      unitRef="usdPershares">5.0985</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <nuwe:PercentageOfFeesPaidToUnderwriterOrPlacementAgentInCash
      contextRef="c69"
      decimals="INF"
      id="ixv-5742"
      unitRef="pure">0.08</nuwe:PercentageOfFeesPaidToUnderwriterOrPlacementAgentInCash>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c70" decimals="2" id="ixv-5743" unitRef="pure">4.19</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c71" decimals="1" id="ixv-5744" unitRef="pure">148.1</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c72" id="ixv-5745">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c73" decimals="2" id="ixv-5746" unitRef="pure">3.8</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c74" decimals="0" id="ixv-5747" unitRef="pure">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="c0" id="ixv-2651">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; The following table summarizes the warrants issued in the January 2026 transactions that remain outstanding as of March 31, 2026: &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;table cellpadding="0" style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt; width: 100%; border-spacing: 0px;"&gt;
   &lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td style="width: 37%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 17%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: bottom;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      &lt;span style="font-style: italic; text-decoration: underline;"&gt;Warrant Type&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; white-space: nowrap;"&gt;
     &lt;div&gt;
      &lt;span style="font-style: italic; text-decoration: underline;"&gt;Shares Underlying&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;&lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom; white-space: nowrap;"&gt;
     &lt;div&gt;
      &lt;span style="font-style: italic; text-decoration: underline;"&gt;Exercise Price&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;&lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: bottom;"&gt;
     &lt;div&gt;
      &lt;span style="font-style: italic; text-decoration: underline;"&gt;Fair Value&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom;"&gt;
     &lt;div&gt;
      &lt;span style="font-style: italic; text-decoration: underline;"&gt;Expiration Date&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: bottom;"&gt;
     &lt;div&gt;
      &lt;span style="font-style: italic; text-decoration: underline;"&gt;Status&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Pre-Funded Warrants
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%; vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;819,296&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;0.0001&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;4.19&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div&gt;
      Upon full exercise
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div&gt;
      Outstanding
     &lt;/div&gt;
    &lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Private Placement Common Warrants
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;1,989,074&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;2.84&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;3.887&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt; &lt;div&gt; January 30, 2031 &lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div&gt;
      Outstanding
     &lt;/div&gt;
    &lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Inducement Warrants
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;1,247,170&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;2.84&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;3.887&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt; &lt;div&gt; &lt;span style="-sec-ix-hidden: hidden-fact-2"&gt;5 years from resale registration effective date&lt;/span&gt; &lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div&gt;
      Outstanding
     &lt;/div&gt;
    &lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Agent Warrants
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;48,544&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;5.0985&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right; vertical-align: middle;"&gt;3.779&lt;/td&gt;&lt;td style="width: 1%; text-align: left; vertical-align: middle;"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt; &lt;div&gt; January 29, 2031 &lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div&gt;
      Outstanding
     &lt;/div&gt;
    &lt;/td&gt;
   &lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c84"
      decimals="INF"
      id="ixv-5748"
      unitRef="shares">819296</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c84"
      decimals="4"
      id="ixv-5749"
      unitRef="usdPershares">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c84"
      decimals="2"
      id="ixv-5750"
      unitRef="usdPershares">4.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c85"
      decimals="INF"
      id="ixv-5751"
      unitRef="shares">1989074</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c85"
      decimals="2"
      id="ixv-5752"
      unitRef="usdPershares">2.84</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c85"
      decimals="3"
      id="ixv-5753"
      unitRef="usdPershares">3.887</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="c86" id="ixv-5754">2031-01-30</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c87"
      decimals="INF"
      id="ixv-5755"
      unitRef="shares">1247170</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c87"
      decimals="2"
      id="ixv-5756"
      unitRef="usdPershares">2.84</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c87"
      decimals="3"
      id="ixv-5757"
      unitRef="usdPershares">3.887</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c88"
      decimals="INF"
      id="ixv-5758"
      unitRef="shares">48544</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c88"
      decimals="4"
      id="ixv-5759"
      unitRef="usdPershares">5.0985</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c88"
      decimals="3"
      id="ixv-5760"
      unitRef="usdPershares">3.779</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable contextRef="c89" id="ixv-5761">2031-01-29</us-gaap:ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable>
    <nuwe:NumberOfSharesAvailableForIssuanceSubjectToExerciseOfWarrants
      contextRef="c75"
      decimals="INF"
      id="ixv-5762"
      unitRef="shares">4104084</nuwe:NumberOfSharesAvailableForIssuanceSubjectToExerciseOfWarrants>
    <nuwe:ClassOfWarrantOrRightUnexercised
      contextRef="c76"
      decimals="INF"
      id="ixv-5763"
      unitRef="shares">6268</nuwe:ClassOfWarrantOrRightUnexercised>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c77" decimals="0" id="ixv-5764" unitRef="usd">6583</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c78"
      decimals="INF"
      id="ixv-5765"
      unitRef="shares">150000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <nuwe:BusinessCombinationConsiderationTransferredOptionsAtClosing
      contextRef="c79"
      decimals="INF"
      id="ixv-5766"
      unitRef="shares">30000</nuwe:BusinessCombinationConsiderationTransferredOptionsAtClosing>
    <nuwe:EquitySecuritiesLockupPeriod contextRef="c80" id="ixv-5767">P6M</nuwe:EquitySecuritiesLockupPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c81"
      decimals="INF"
      id="ixv-5768"
      unitRef="shares">768535</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <nuwe:ProceedsFromIssuanceOfCommonStockNet contextRef="c81" decimals="-5" id="ixv-5769" unitRef="usd">2900000</nuwe:ProceedsFromIssuanceOfCommonStockNet>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c82"
      decimals="INF"
      id="ixv-5770"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c0" id="ixv-2804">&lt;div style="font-weight: bold; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   Note 4 - Stock-Based Compensation
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   Under the fair value recognition provisions of U.S. GAAP for accounting for stock-based compensation, the Company measures stock-based compensation expense at the grant date based on the fair value of the award and recognizes the compensation expense over the requisite service period, which is generally the vesting period.
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; The following table presents the classification of stock-based compensation expense recognized for the periods below: &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;table cellpadding="0" style="font-size: 10pt; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
   &lt;tr style="height: 0px; font-size: 0px;"&gt;
    &lt;td style="width: 76%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;

   &lt;/tr&gt;
   &lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="6" style="width: 1%; text-align: center; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; border-width: medium medium 2px; border-style: none none solid;"&gt;&lt;b&gt; Three months ended&lt;br/&gt;March 31    &lt;/b&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr&gt;
    &lt;td&gt;
     &lt;div&gt;
      (in thousands)
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&lt;br/&gt;&lt;/td&gt;&lt;td colspan="2" style="border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%; text-align: center;"&gt; &lt;span style="letter-spacing: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%; text-align: center;"&gt;&lt;b&gt;


      2025
     &lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="background-color: rgb(204, 238, 255);"&gt;
    &lt;td&gt;
     &lt;div&gt;
      Selling, general and administrative expense
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;24&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;

    &lt;td style="width: 9%; text-align: right;"&gt;65&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr&gt;
    &lt;td&gt;
     &lt;div&gt;
      Research and development expense
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right; border-bottom: 2px solid black;"&gt;1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 1%; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 9%; text-align: right; border-bottom: 2px solid black;"&gt;2&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="font-weight: bold; padding-left: 10px;"&gt;
     &lt;div&gt;
      Total stock-based compensation expense
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: 4px double transparent;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-weight: bold; border-bottom: 4px double black;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right; font-weight: bold; border-bottom: 4px double black;"&gt;25&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-weight: bold; border-bottom: 4px double transparent;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 1%; border-bottom: 4px double transparent;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-weight: bold; border-bottom: 4px double black;"&gt;$&lt;/td&gt;

    &lt;td style="width: 9%; text-align: right; font-weight: bold; border-bottom: 4px double black;"&gt;67&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-weight: bold; border-bottom: 4px double transparent;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;

  &lt;/table&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; During the three months ended March 31, 2026 and 2025, under the 2017 Equity Incentive Plan, and the 2021 Inducement Plan, the Company granted 0 stock options for both periods to its directors, officers and employees. Vesting generally occurs either immediately or up to a 48-month period based on a time-of-service condition. As the Company did not issue any stock options during the three months ended March 31, 2026, there is no weighted-average grant date fair value of the stock options issued during the three months ended March 31, 2026. The weighted-average grant date fair value of the stock options issued during the three months ended March 31, 2026, and 2025 was $0 and $0 per share, respectively. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; &#160;The total number of stock options outstanding as of March 31, 2026, and 2025 was 34,446 and 81, respectively. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; During the three months ended March 31, 2026, and 2025, 1,097 and 4 stock options vested, respectively, and 6 and 12 stock options expired or were forfeited during these periods, respectively. During the three months ended March 31, 2026, and 2025, no options were exercised. &lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c0" id="ixv-2809">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; The following table presents the classification of stock-based compensation expense recognized for the periods below: &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;table cellpadding="0" style="font-size: 10pt; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
   &lt;tr style="height: 0px; font-size: 0px;"&gt;
    &lt;td style="width: 76%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;

   &lt;/tr&gt;
   &lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="6" style="width: 1%; text-align: center; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; border-width: medium medium 2px; border-style: none none solid;"&gt;&lt;b&gt; Three months ended&lt;br/&gt;March 31    &lt;/b&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr&gt;
    &lt;td&gt;
     &lt;div&gt;
      (in thousands)
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&lt;br/&gt;&lt;/td&gt;&lt;td colspan="2" style="border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%; text-align: center;"&gt; &lt;span style="letter-spacing: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); width: 1%; text-align: center;"&gt;&lt;b&gt;


      2025
     &lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="background-color: rgb(204, 238, 255);"&gt;
    &lt;td&gt;
     &lt;div&gt;
      Selling, general and administrative expense
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right;"&gt;24&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt;

    &lt;td style="width: 9%; text-align: right;"&gt;65&lt;/td&gt;&lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr&gt;
    &lt;td&gt;
     &lt;div&gt;
      Research and development expense
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right; border-bottom: 2px solid black;"&gt;1&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 1%; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 9%; text-align: right; border-bottom: 2px solid black;"&gt;2&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="font-weight: bold; padding-left: 10px;"&gt;
     &lt;div&gt;
      Total stock-based compensation expense
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: 4px double transparent;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-weight: bold; border-bottom: 4px double black;"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right; font-weight: bold; border-bottom: 4px double black;"&gt;25&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-weight: bold; border-bottom: 4px double transparent;"&gt;&#160;&lt;/td&gt;

    &lt;td style="width: 1%; border-bottom: 4px double transparent;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-weight: bold; border-bottom: 4px double black;"&gt;$&lt;/td&gt;

    &lt;td style="width: 9%; text-align: right; font-weight: bold; border-bottom: 4px double black;"&gt;67&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-weight: bold; border-bottom: 4px double transparent;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;

  &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c92" decimals="-3" id="ixv-5771" unitRef="usd">24000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c93" decimals="-3" id="ixv-5772" unitRef="usd">65000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c94" decimals="-3" id="ixv-5773" unitRef="usd">1000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c95" decimals="-3" id="ixv-5774" unitRef="usd">2000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c0" decimals="-3" id="ixv-5775" unitRef="usd">25000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c12" decimals="-3" id="ixv-5776" unitRef="usd">67000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c90"
      decimals="INF"
      id="ixv-5777"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c91"
      decimals="INF"
      id="ixv-5778"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c0" id="ixv-5779">P48M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c90"
      decimals="INF"
      id="ixv-5780"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c90"
      decimals="0"
      id="ixv-5781"
      unitRef="usdPershares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c90"
      decimals="INF"
      id="ixv-5782"
      unitRef="usdPershares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c91"
      decimals="INF"
      id="ixv-5783"
      unitRef="usdPershares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c2"
      decimals="INF"
      id="ixv-5784"
      unitRef="shares">34446</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c26"
      decimals="INF"
      id="ixv-5785"
      unitRef="shares">81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="c90"
      decimals="INF"
      id="ixv-5786"
      unitRef="shares">1097</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="c91"
      decimals="INF"
      id="ixv-5787"
      unitRef="shares">4</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="c90"
      decimals="INF"
      id="ixv-5788"
      unitRef="shares">6</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="c91"
      decimals="INF"
      id="ixv-5789"
      unitRef="shares">12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c90"
      decimals="0"
      id="ixv-5790"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c91"
      decimals="0"
      id="ixv-5791"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c0" id="ixv-2891">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   &lt;span style="font-weight: bold;"&gt;Note 5&#x2014;Fair Value&lt;/span&gt;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   The Company&#x2019;s financial instruments consist of cash and cash equivalents and warrants.
  &lt;/div&gt;&lt;div style="text-align: center; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   Pursuant to the requirements of Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 820 &#x201c;Fair Value Measurement,&#x201d; the Company&#x2019;s financial assets and liabilities measured at fair value on a recurring basis are classified and disclosed in one of the following three categories:
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="text-indent: -18pt; padding-left: 18pt;"&gt;
    &lt;div style="float: left; width: 18pt; white-space: nowrap; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
     &#x25cf;
    &lt;/div&gt;
    &lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
     Level 1 - Financial instruments with unadjusted quoted prices listed on active market exchanges.
    &lt;/div&gt;
  &lt;/div&gt;&lt;div style="margin-left: 18pt; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="text-indent: -18pt; padding-left: 18pt;"&gt;
    &lt;div style="float: left; width: 18pt; white-space: nowrap; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
     &#x25cf;
    &lt;/div&gt;
    &lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
     Level 2 - Financial instruments lacking unadjusted, quoted prices from active market exchanges, including over-the-counter traded financial instruments. The prices for the financial instruments are determined using prices for recently traded financial instruments with similar underlying terms as well as directly or indirectly observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.
    &lt;/div&gt;
  &lt;/div&gt;&lt;div style="margin-left: 18pt; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="text-indent: -18pt; padding-left: 18pt;"&gt;
    &lt;div style="float: left; width: 18pt; white-space: nowrap; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
     &#x25cf;
    &lt;/div&gt;
    &lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
     Level 3 - Financial instruments that are not actively traded on a market exchange. This category includes situations where there is little, if any, market activity for the financial instrument. The prices are determined using significant unobservable inputs or valuation techniques.
    &lt;/div&gt;
  &lt;/div&gt;&lt;div style="margin-left: 18pt; font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   The fair value of the Company&#x2019;s common and preferred stock warrant liabilities related to the warrants issued in the October 2022, October 2023, April 2024 and June 2025 public offerings were calculated using a Monte Carlo valuation model and were classified as Level 3 in the fair value hierarchy.
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; The deferred consideration liability related to the Rendiatech asset acquisition (additional cash payments due in 2026 and 2027) is also classified as Level 3. The liability was initially measured at its fair value of $313 thousand on the acquisition date of March 17, 2026, using a discount rate of 13.38% (Company&#x2019;s estimated credit risk rate based on a CCC bond yield). &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; The carrying value of the deferred consideration liability approximates its fair value as of March 31, 2026.&lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
   &lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td style="width: 76%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      &lt;span style="font-style: italic;"&gt;(in thousands)&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align: middle; width: 1%; text-align: center; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; border-width: medium medium 2px; border-style: none none solid;"&gt;


      &lt;span style="font-weight: bold;"&gt;March 31,&lt;br/&gt; 2026&lt;/span&gt;
     &lt;/td&gt;&lt;td style="border-width: medium; border-style: none; border-color: currentcolor; vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: middle; text-align: right; width: 1%; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align: middle; width: 1%; text-align: center; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; border-width: medium medium 2px; border-style: none none solid;"&gt;


      &lt;span style="font-weight: bold;"&gt;December 31,&lt;br/&gt; 2025&lt;/span&gt;
     &lt;/td&gt;&lt;td style="border-width: medium; border-style: none; border-color: currentcolor; vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Warrant liability Series B
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%;"&gt;6&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%;"&gt;12&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Warrant liability Series J
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%;"&gt;355&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%;"&gt;377&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Deferred consideration liability (Rendiatech)
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%; border-bottom: 2px solid black;"&gt;313&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%; border-bottom: 2px solid black;"&gt; &#x2014; &lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle; padding-left: 10px;"&gt;
     &lt;div&gt;
      &lt;span style="font-weight: bold;"&gt;Total Level 3 liabilities&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; font-weight: bold; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; font-weight: bold; width: 1%;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; font-weight: bold; width: 9%;"&gt;674&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; font-weight: bold; width: 1%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: middle; text-align: right; font-weight: bold; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; font-weight: bold; width: 1%;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; font-weight: bold; width: 9%;"&gt;389&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; font-weight: bold; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
  &lt;/table&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; The following is a roll-forward of the fair value of the Level 3 liabilities:&lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
   &lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td style="width: 64%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      &lt;span style="font-style: italic;"&gt;(in thousands)&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align: middle; text-align: center; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; border-width: medium medium 2px; border-style: none none solid;"&gt;


      &lt;span style="font-weight: bold;"&gt;Warrant&lt;br/&gt; Liabilities&lt;/span&gt;
     &lt;/td&gt;&lt;td style="border-width: medium; border-style: none; border-color: currentcolor; vertical-align: middle; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: middle; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align: middle; text-align: center; width: 1%; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; border-width: medium medium 2px; border-style: none none solid;"&gt;


      &lt;span style="font-weight: bold;"&gt;Deferred&lt;br/&gt; Consideration&lt;/span&gt;
     &lt;/td&gt;&lt;td style="border-width: medium; border-style: none; border-color: currentcolor; vertical-align: middle; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: middle; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); vertical-align: middle; text-align: center; width: 1%;"&gt;


      &lt;span style="font-weight: bold;"&gt;Total&lt;/span&gt;
     &lt;/td&gt;&lt;td style="border-width: medium; border-style: none; border-color: currentcolor; vertical-align: middle; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Balance at December 31, 2025
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;389&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td style="text-align: right; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt; &#x2014; &lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td style="text-align: right; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;389&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Acquisition of Rendiatech (initial fair value)
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt; &#x2014; &lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;313&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;313&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Exercise of Series B warrants
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;(2&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;)&#160;&lt;/td&gt;

    &lt;td style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt; &#x2014; &lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;(2&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;)&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Change in fair value
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;(26&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;)&#160;&lt;/td&gt;

    &lt;td style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt; &#x2014; &lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;(26&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;)&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      &lt;span style="font-weight: bold;"&gt;Balance at March 31, 2026&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; font-weight: bold; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; font-weight: bold; width: 1%; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-weight: bold; width: 9%; vertical-align: bottom;"&gt;361&lt;/td&gt;&lt;td style="text-align: left; font-weight: bold; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td style="text-align: right; font-weight: bold; vertical-align: bottom; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; font-weight: bold; width: 1%; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-weight: bold; width: 9%; vertical-align: bottom;"&gt;313&lt;/td&gt;&lt;td style="text-align: left; font-weight: bold; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td style="text-align: right; font-weight: bold; vertical-align: bottom; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; font-weight: bold; width: 1%; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-weight: bold; width: 9%; vertical-align: bottom;"&gt;674&lt;/td&gt;&lt;td style="text-align: left; font-weight: bold; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
  &lt;/table&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c96" decimals="-3" id="ixv-5792" unitRef="usd">313000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:AssetAcquisitionEffectiveDateOfAcquisition contextRef="c97" id="ixv-5793">2026-03-17</us-gaap:AssetAcquisitionEffectiveDateOfAcquisition>
    <nuwe:DeferredConsiderationDiscountRate contextRef="c96" decimals="4" id="ixv-5794" unitRef="pure">0.1338</nuwe:DeferredConsiderationDiscountRate>
    <nuwe:WarrantLiabilitiesAndDeferredConsiderationLiabilityTableTextBlock contextRef="c0" id="ixv-2915">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; The carrying value of the deferred consideration liability approximates its fair value as of March 31, 2026.&lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
   &lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td style="width: 76%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      &lt;span style="font-style: italic;"&gt;(in thousands)&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align: middle; width: 1%; text-align: center; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; border-width: medium medium 2px; border-style: none none solid;"&gt;


      &lt;span style="font-weight: bold;"&gt;March 31,&lt;br/&gt; 2026&lt;/span&gt;
     &lt;/td&gt;&lt;td style="border-width: medium; border-style: none; border-color: currentcolor; vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: middle; text-align: right; width: 1%; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align: middle; width: 1%; text-align: center; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; border-width: medium medium 2px; border-style: none none solid;"&gt;


      &lt;span style="font-weight: bold;"&gt;December 31,&lt;br/&gt; 2025&lt;/span&gt;
     &lt;/td&gt;&lt;td style="border-width: medium; border-style: none; border-color: currentcolor; vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Warrant liability Series B
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%;"&gt;6&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%;"&gt;12&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%; border-width: medium; border-style: none; border-color: currentcolor;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Warrant liability Series J
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%;"&gt;355&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%;"&gt;377&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Deferred consideration liability (Rendiatech)
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%; border-bottom: 2px solid black;"&gt;313&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%; border-bottom: 2px solid black;"&gt; &#x2014; &lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle; padding-left: 10px;"&gt;
     &lt;div&gt;
      &lt;span style="font-weight: bold;"&gt;Total Level 3 liabilities&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; font-weight: bold; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; font-weight: bold; width: 1%;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; font-weight: bold; width: 9%;"&gt;674&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; font-weight: bold; width: 1%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: middle; text-align: right; font-weight: bold; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; font-weight: bold; width: 1%;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; font-weight: bold; width: 9%;"&gt;389&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; font-weight: bold; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
  &lt;/table&gt;</nuwe:WarrantLiabilitiesAndDeferredConsiderationLiabilityTableTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c98" decimals="-3" id="ixv-5795" unitRef="usd">6000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c99" decimals="-3" id="ixv-5796" unitRef="usd">12000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c100" decimals="-3" id="ixv-5797" unitRef="usd">355000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c101" decimals="-3" id="ixv-5798" unitRef="usd">377000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c102" decimals="-3" id="ixv-5799" unitRef="usd">313000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c103" decimals="-3" id="ixv-5800" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c2" decimals="-3" id="ixv-5801" unitRef="usd">674000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c3" decimals="-3" id="ixv-5802" unitRef="usd">389000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c0" id="ixv-2996">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; The following is a roll-forward of the fair value of the Level 3 liabilities:&lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
   &lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td style="width: 64%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      &lt;span style="font-style: italic;"&gt;(in thousands)&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align: middle; text-align: center; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; border-width: medium medium 2px; border-style: none none solid;"&gt;


      &lt;span style="font-weight: bold;"&gt;Warrant&lt;br/&gt; Liabilities&lt;/span&gt;
     &lt;/td&gt;&lt;td style="border-width: medium; border-style: none; border-color: currentcolor; vertical-align: middle; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: middle; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align: middle; text-align: center; width: 1%; border-color: currentcolor currentcolor rgb(0, 0, 0); white-space: nowrap; border-width: medium medium 2px; border-style: none none solid;"&gt;


      &lt;span style="font-weight: bold;"&gt;Deferred&lt;br/&gt; Consideration&lt;/span&gt;
     &lt;/td&gt;&lt;td style="border-width: medium; border-style: none; border-color: currentcolor; vertical-align: middle; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;

    &lt;td style="vertical-align: middle; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); vertical-align: middle; text-align: center; width: 1%;"&gt;


      &lt;span style="font-weight: bold;"&gt;Total&lt;/span&gt;
     &lt;/td&gt;&lt;td style="border-width: medium; border-style: none; border-color: currentcolor; vertical-align: middle; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Balance at December 31, 2025
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;389&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td style="text-align: right; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt; &#x2014; &lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td style="text-align: right; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;389&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Acquisition of Rendiatech (initial fair value)
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt; &#x2014; &lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;313&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;313&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Exercise of Series B warrants
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;(2&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;)&#160;&lt;/td&gt;

    &lt;td style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt; &#x2014; &lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;(2&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;)&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Change in fair value
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;(26&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;)&#160;&lt;/td&gt;

    &lt;td style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt; &#x2014; &lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td style="text-align: right; vertical-align: bottom; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 9%; vertical-align: bottom;"&gt;(26&lt;/td&gt;&lt;td style="text-align: left; width: 1%; vertical-align: bottom;"&gt;)&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      &lt;span style="font-weight: bold;"&gt;Balance at March 31, 2026&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; font-weight: bold; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; font-weight: bold; width: 1%; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-weight: bold; width: 9%; vertical-align: bottom;"&gt;361&lt;/td&gt;&lt;td style="text-align: left; font-weight: bold; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td style="text-align: right; font-weight: bold; vertical-align: bottom; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; font-weight: bold; width: 1%; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-weight: bold; width: 9%; vertical-align: bottom;"&gt;313&lt;/td&gt;&lt;td style="text-align: left; font-weight: bold; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;

    &lt;td style="text-align: right; font-weight: bold; vertical-align: bottom; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; font-weight: bold; width: 1%; vertical-align: bottom;"&gt;$&lt;/td&gt;&lt;td style="text-align: right; font-weight: bold; width: 9%; vertical-align: bottom;"&gt;674&lt;/td&gt;&lt;td style="text-align: left; font-weight: bold; width: 1%; vertical-align: bottom;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
  &lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c104" decimals="-3" id="ixv-5803" unitRef="usd">389000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c105" decimals="-3" id="ixv-5804" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c3" decimals="-3" id="ixv-5805" unitRef="usd">389000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <nuwe:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditionalCashPayments contextRef="c106" decimals="-3" id="ixv-5806" unitRef="usd">0</nuwe:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditionalCashPayments>
    <nuwe:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditionalCashPayments contextRef="c107" decimals="-3" id="ixv-5807" unitRef="usd">313000</nuwe:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditionalCashPayments>
    <nuwe:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditionalCashPayments contextRef="c108" decimals="-3" id="ixv-5808" unitRef="usd">313000</nuwe:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditionalCashPayments>
    <nuwe:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssuesExerciseOfWarrants contextRef="c109" decimals="-3" id="ixv-5809" unitRef="usd">-2000</nuwe:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssuesExerciseOfWarrants>
    <nuwe:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssuesExerciseOfWarrants contextRef="c110" decimals="-3" id="ixv-5810" unitRef="usd">0</nuwe:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssuesExerciseOfWarrants>
    <nuwe:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssuesExerciseOfWarrants contextRef="c111" decimals="-3" id="ixv-5811" unitRef="usd">-2000</nuwe:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssuesExerciseOfWarrants>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease contextRef="c112" decimals="-3" id="ixv-5812" unitRef="usd">-26000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease contextRef="c113" decimals="-3" id="ixv-5813" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease contextRef="c114" decimals="-3" id="ixv-5814" unitRef="usd">-26000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c115" decimals="-3" id="ixv-5815" unitRef="usd">361000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c116" decimals="-3" id="ixv-5816" unitRef="usd">313000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c2" decimals="-3" id="ixv-5817" unitRef="usd">674000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c0" id="ixv-3110">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   &lt;span style="font-weight: bold;"&gt;Note 6 &#x2013; Income Taxes&lt;/span&gt;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   The Company provides for a valuation allowance when it is more likely than not that it will not realize a portion of its deferred tax assets. The Company has established a full valuation allowance for its U.S. and foreign deferred tax assets due to the uncertainty that enough taxable income will be generated in those taxing jurisdictions to utilize the assets. Therefore, the Company has not reflected any benefit of such deferred tax assets in the accompanying condensed consolidated financial statements.
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   As of March 31, 2026, there were no material changes to what the Company disclosed regarding tax uncertainties or penalties in its Annual Report on Form 10-K for the year ended December 31, 2025.
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   On July 4, 2025, the One Big Beautiful Bill Act (OBBBA) was enacted and the Company continues to evaluate the impact on its financial position. The OBBBA is not currently expected to materially impact the Company&#x2019;s effective tax rate or cash flows in the current fiscal year.
  &lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c0" id="ixv-3120">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   &lt;span style="font-weight: bold;"&gt;Note 7&#x2014;Operating Leases&lt;/span&gt;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; The Company leases a 23,000 square foot facility located in Eden Prairie, Minnesota for office and manufacturing space under a non-cancelable operating lease that expires in March 2027. In November 2021, the Company entered into a fourth amendment to the lease, extending the term of the lease from March 31, 2022 to March 31, 2027. This facility serves as our corporate headquarters and houses substantially all our functional departments. Monthly rent and common area maintenance charges, including estimated property tax for our headquarters, total approximately $36 thousand. The lease contains provisions for annual inflationary adjustments. Rent expense is being recorded on a straight-line basis over the term of the lease. Beginning on April 1, 2022, the annual base rent was $10.50 per square foot, subject to future annual increases of $0.32 to $0.34 per square foot. &lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <nuwe:OperatingLeaseAreaForLease contextRef="c0" decimals="INF" id="ixv-5818" unitRef="Sqft">23000</nuwe:OperatingLeaseAreaForLease>
    <nuwe:OperatingLeaseMonthlyRentAndCommonAreaMaintenanceCharges contextRef="c0" decimals="-3" id="ixv-5819" unitRef="usd">36000</nuwe:OperatingLeaseMonthlyRentAndCommonAreaMaintenanceCharges>
    <nuwe:AnnualBaseRentPerSquareFoot contextRef="c0" decimals="2" id="ixv-5820" unitRef="Sqft">10.5</nuwe:AnnualBaseRentPerSquareFoot>
    <nuwe:AnnualBaseRentIncreasePerSquareFoot contextRef="c117" decimals="2" id="ixv-5821" unitRef="Sqft">0.32</nuwe:AnnualBaseRentIncreasePerSquareFoot>
    <nuwe:AnnualBaseRentIncreasePerSquareFoot contextRef="c118" decimals="2" id="ixv-5822" unitRef="Sqft">0.34</nuwe:AnnualBaseRentIncreasePerSquareFoot>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c0" id="ixv-3126">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   &lt;span style="font-weight: bold;"&gt;Note 8&#x2014;Commitments and Contingencies&lt;/span&gt;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   &lt;span style="font-style: italic;"&gt;Employee Retirement Plan: &lt;/span&gt;The Company has a 401(k) retirement plan that provides retirement benefits to all eligible U.S. employees. Eligible employees may contribute a percentage of their annual compensation, subject to Internal Revenue Service limitations, with the Company matching a portion of the employees&#x2019; contributions at the discretion of the Company.
  &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c0" id="ixv-3133">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   &lt;span style="font-weight: bold;"&gt;Note 9&#x2014;Segment Reporting&lt;/span&gt;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker (the &#x201c;CODM&#x201d;), or decision-making group, in deciding how to allocate resources in assessing performance. Nuwellis has one reportable segment: fluid overload. The Company is a medical technology company focused on developing and commercializing the Aquadex System. The Company recognizes this medical device system as one reporting segment. The CODM is the chief executive officer. &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   The accounting policies of the fluid overload segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance for the fluid overload segment based on net loss, which is reported on the statement of operations as consolidated net loss. The measure of segment assets is reported on the balance sheet as total consolidated assets. The Company does not have any intra-entity sales or transfers.
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   The CODM uses cash forecast models in deciding how to invest into the fluid overload segment. Such cash forecast models are reviewed to assess the entity-wide operating results and performance. Net income (loss) is used to monitor budget versus actual results. Monitoring budgeted versus actual results is used in assessing performance of the segment and in establishing management&#x2019;s compensation.
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; The table below summarizes the significant expense categories regularly reviewed by the CODM for the three months ended March 31, 2026 and 2025: &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;
 &lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td style="width: 76%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="mso-yfti-irow:0;mso-yfti-firstrow:yes;height:1.0pt"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="height: 1pt; text-align: center; width: 1%;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;&lt;br/&gt;&lt;/div&gt;
  &lt;/td&gt;&lt;td colspan="6" style="text-align : center; width : 1%; white-space : nowrap; " valign="top"&gt;
&lt;div style="letter-spacing: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin: 0in;"&gt;&lt;b&gt;Three months ended&lt;/b&gt;&lt;/div&gt;&lt;div style="letter-spacing: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin: 0in;"&gt;&lt;b&gt;March 31&lt;/b&gt;&lt;/div&gt;
     &lt;/td&gt;&lt;td style="text-align: center; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:1;height:1.0pt"&gt;
  &lt;td style="height: 1pt; border-bottom: 2px solid rgb(0, 0, 0); border-top-width: medium; border-top-style: none; border-top-color: currentcolor; border-left-width: medium; border-left-style: none; border-left-color: currentcolor; text-align: center;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="border-bottom: 2px solid rgb(0, 0, 0); border-top-width: medium; border-top-style: none; border-top-color: currentcolor; text-align: center; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0); border-top-width: medium; border-top-style: none; border-top-color: currentcolor; text-align: center; width: 1%;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;&lt;b style="mso-bidi-font-weight:normal"&gt;2026 &lt;/b&gt;&lt;/div&gt;
  &lt;/td&gt;&lt;td style="border-bottom: 2px solid rgb(0, 0, 0); border-top-width: medium; border-top-style: none; border-top-color: currentcolor; text-align: center; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="border-bottom: 2px solid rgb(0, 0, 0); border-top-width: medium; border-top-style: none; border-top-color: currentcolor; text-align: center; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0); border-top-width: medium; border-top-style: none; border-top-color: currentcolor; text-align: center; width: 1%;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;&lt;b style="mso-bidi-font-weight:normal"&gt;2025&lt;/b&gt;&lt;/div&gt;
  &lt;/td&gt;&lt;td style="border-bottom: 2px solid rgb(0, 0, 0); border-top-width: medium; border-top-style: none; border-top-color: currentcolor; border-right-width: medium; border-right-style: none; border-right-color: currentcolor; text-align: center; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="height: 1pt; background-color: rgb(204, 238, 255);"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in; text-indent: -0.1in;"&gt;&lt;b style="mso-bidi-font-weight:normal"&gt;Revenue&lt;/b&gt;&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;$&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right;" valign="top"&gt;2,403&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;$&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right;" valign="top"&gt;1,904&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:3;height:1.0pt"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in; text-indent: -0.1in;"&gt;&lt;b style="mso-bidi-font-weight:normal"&gt;Gross Profit&lt;/b&gt;&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid black;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-bottom: 2px solid black;" valign="top"&gt;1,684&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid black;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-bottom: 2px solid black;" valign="top"&gt;1,067&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="height: 1pt; background-color: rgb(204, 238, 255);"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in; text-indent: -0.1in;"&gt;Gross profit %&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid black;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-bottom: 2px solid black;" valign="top"&gt;70.1&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid transparent;" valign="top"&gt;%&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid black;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-bottom: 2px solid black;" valign="top"&gt;56.0&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid transparent;" valign="top"&gt;%&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:5;height:1.0pt"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in; text-indent: -0.1in;"&gt;&lt;b style="mso-bidi-font-weight:normal"&gt;Operating expenses:&lt;/b&gt;&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; width: 9%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; width: 9%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="height: 1pt; background-color: rgb(204, 238, 255);"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in;"&gt;General and
  administrative&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right;" valign="top"&gt;2,371&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right;" valign="top"&gt;1,846&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:7;height:1.0pt"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in;"&gt;Sales and
  marketing&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right;" valign="top"&gt;2,084&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right;" valign="top"&gt;1,430&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="height: 1pt; background-color: rgb(204, 238, 255);"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in;"&gt;Development&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right;" valign="top"&gt;1,397&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right;" valign="top"&gt;206&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:9;height:1.0pt"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in;"&gt;Clinical,
  Quality, Regulatory&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid black;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-bottom: 2px solid black;" valign="top"&gt;400&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid black;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-bottom: 2px solid black;" valign="top"&gt;578&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="height: 1pt; background-color: rgb(204, 238, 255);"&gt;
  &lt;td style="height: 1pt; padding-left: 10px;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in;"&gt;Total operating
  expenses&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid black;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-bottom: 2px solid black;" valign="top"&gt;6,252&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid black;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-bottom: 2px solid black;" valign="top"&gt;4,060&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:11;height:1.0pt"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in;"&gt;Stock Based
  Compensation&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right;" valign="top"&gt; - &lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right;" valign="top"&gt;67&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="height: 1pt; background-color: rgb(204, 238, 255);"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in;"&gt;Other income (expense)&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" valign="top"&gt;(27&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;)&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" valign="top"&gt;(46&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;)&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:13;mso-yfti-lastrow:yes;height:1.0pt"&gt;
  &lt;td style="height: 1pt; padding-left: 10px;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in;"&gt;&lt;b style="mso-bidi-font-weight:normal"&gt;Net income (loss)&lt;/b&gt;&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); font-weight: bold;" valign="top"&gt;$&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); font-weight: bold;" valign="top"&gt;(4,541&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor; font-weight: bold;" valign="top"&gt;)&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); font-weight: bold;" valign="top"&gt;$&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); font-weight: bold;" valign="top"&gt;(3,014&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor; font-weight: bold;" valign="top"&gt;)&#160;&lt;/td&gt;
 &lt;/tr&gt;
&lt;/table&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c0"
      decimals="INF"
      id="ixv-5823"
      unitRef="Segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="c0"
      decimals="INF"
      id="ixv-5824"
      unitRef="Segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c0" id="ixv-3150">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; The table below summarizes the significant expense categories regularly reviewed by the CODM for the three months ended March 31, 2026 and 2025: &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;table cellpadding="0" style="border-collapse: collapse; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;
 &lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td style="width: 76%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="mso-yfti-irow:0;mso-yfti-firstrow:yes;height:1.0pt"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="height: 1pt; text-align: center; width: 1%;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;&lt;br/&gt;&lt;/div&gt;
  &lt;/td&gt;&lt;td colspan="6" style="text-align : center; width : 1%; white-space : nowrap; " valign="top"&gt;
&lt;div style="letter-spacing: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin: 0in;"&gt;&lt;b&gt;Three months ended&lt;/b&gt;&lt;/div&gt;&lt;div style="letter-spacing: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin: 0in;"&gt;&lt;b&gt;March 31&lt;/b&gt;&lt;/div&gt;
     &lt;/td&gt;&lt;td style="text-align: center; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:1;height:1.0pt"&gt;
  &lt;td style="height: 1pt; border-bottom: 2px solid rgb(0, 0, 0); border-top-width: medium; border-top-style: none; border-top-color: currentcolor; border-left-width: medium; border-left-style: none; border-left-color: currentcolor; text-align: center;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="border-bottom: 2px solid rgb(0, 0, 0); border-top-width: medium; border-top-style: none; border-top-color: currentcolor; text-align: center; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0); border-top-width: medium; border-top-style: none; border-top-color: currentcolor; text-align: center; width: 1%;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;&lt;b style="mso-bidi-font-weight:normal"&gt;2026 &lt;/b&gt;&lt;/div&gt;
  &lt;/td&gt;&lt;td style="border-bottom: 2px solid rgb(0, 0, 0); border-top-width: medium; border-top-style: none; border-top-color: currentcolor; text-align: center; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="border-bottom: 2px solid rgb(0, 0, 0); border-top-width: medium; border-top-style: none; border-top-color: currentcolor; text-align: center; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0); border-top-width: medium; border-top-style: none; border-top-color: currentcolor; text-align: center; width: 1%;" valign="top"&gt;
  &lt;div style="margin: 0in;"&gt;&lt;b style="mso-bidi-font-weight:normal"&gt;2025&lt;/b&gt;&lt;/div&gt;
  &lt;/td&gt;&lt;td style="border-bottom: 2px solid rgb(0, 0, 0); border-top-width: medium; border-top-style: none; border-top-color: currentcolor; border-right-width: medium; border-right-style: none; border-right-color: currentcolor; text-align: center; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="height: 1pt; background-color: rgb(204, 238, 255);"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in; text-indent: -0.1in;"&gt;&lt;b style="mso-bidi-font-weight:normal"&gt;Revenue&lt;/b&gt;&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;$&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right;" valign="top"&gt;2,403&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;$&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right;" valign="top"&gt;1,904&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:3;height:1.0pt"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in; text-indent: -0.1in;"&gt;&lt;b style="mso-bidi-font-weight:normal"&gt;Gross Profit&lt;/b&gt;&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid black;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-bottom: 2px solid black;" valign="top"&gt;1,684&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid black;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-bottom: 2px solid black;" valign="top"&gt;1,067&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="height: 1pt; background-color: rgb(204, 238, 255);"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in; text-indent: -0.1in;"&gt;Gross profit %&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid black;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-bottom: 2px solid black;" valign="top"&gt;70.1&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid transparent;" valign="top"&gt;%&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid black;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-bottom: 2px solid black;" valign="top"&gt;56.0&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid transparent;" valign="top"&gt;%&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:5;height:1.0pt"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in; text-indent: -0.1in;"&gt;&lt;b style="mso-bidi-font-weight:normal"&gt;Operating expenses:&lt;/b&gt;&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; width: 9%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; width: 9%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="height: 1pt; background-color: rgb(204, 238, 255);"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in;"&gt;General and
  administrative&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right;" valign="top"&gt;2,371&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right;" valign="top"&gt;1,846&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:7;height:1.0pt"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in;"&gt;Sales and
  marketing&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right;" valign="top"&gt;2,084&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right;" valign="top"&gt;1,430&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="height: 1pt; background-color: rgb(204, 238, 255);"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in;"&gt;Development&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right;" valign="top"&gt;1,397&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right;" valign="top"&gt;206&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:9;height:1.0pt"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in;"&gt;Clinical,
  Quality, Regulatory&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid black;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-bottom: 2px solid black;" valign="top"&gt;400&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid black;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-bottom: 2px solid black;" valign="top"&gt;578&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="height: 1pt; background-color: rgb(204, 238, 255);"&gt;
  &lt;td style="height: 1pt; padding-left: 10px;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in;"&gt;Total operating
  expenses&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid black;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-bottom: 2px solid black;" valign="top"&gt;6,252&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid black;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-bottom: 2px solid black;" valign="top"&gt;4,060&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-bottom: 2px solid transparent;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:11;height:1.0pt"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in;"&gt;Stock Based
  Compensation&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right;" valign="top"&gt; - &lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right;" valign="top"&gt;67&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="height: 1pt; background-color: rgb(204, 238, 255);"&gt;
  &lt;td style="height: 1pt;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in;"&gt;Other income (expense)&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" valign="top"&gt;(27&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;)&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0);" valign="top"&gt;(46&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor;" valign="top"&gt;)&#160;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="mso-yfti-irow:13;mso-yfti-lastrow:yes;height:1.0pt"&gt;
  &lt;td style="height: 1pt; padding-left: 10px;" valign="top"&gt;
  &lt;div style="margin: 0in 0in 0in 0.1in;"&gt;&lt;b style="mso-bidi-font-weight:normal"&gt;Net income (loss)&lt;/b&gt;&lt;/div&gt;
  &lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); font-weight: bold;" valign="top"&gt;$&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); font-weight: bold;" valign="top"&gt;(4,541&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor; font-weight: bold;" valign="top"&gt;)&#160;&lt;/td&gt;
  &lt;td style="margin: 0in; width: 1%;" valign="top"&gt;&#160;&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); font-weight: bold;" valign="top"&gt;$&lt;/td&gt;&lt;td style="height: 1pt; margin: 0in; width: 9%; text-align: right; border-width: medium medium 2px; border-style: none none solid; border-color: currentcolor currentcolor rgb(0, 0, 0); font-weight: bold;" valign="top"&gt;(3,014&lt;/td&gt;&lt;td style="margin: 0in; width: 1%; text-align: left; border-width: medium; border-style: none; border-color: currentcolor; font-weight: bold;" valign="top"&gt;)&#160;&lt;/td&gt;
 &lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c119" decimals="-3" id="ixv-5825" unitRef="usd">2403000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c120" decimals="-3" id="ixv-5826" unitRef="usd">1904000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit contextRef="c119" decimals="-3" id="ixv-5827" unitRef="usd">1684000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c120" decimals="-3" id="ixv-5828" unitRef="usd">1067000</us-gaap:GrossProfit>
    <nuwe:PercentageOfGrossProfitit contextRef="c119" decimals="3" id="ixv-5829" unitRef="pure">0.701</nuwe:PercentageOfGrossProfitit>
    <nuwe:PercentageOfGrossProfitit contextRef="c120" decimals="3" id="ixv-5830" unitRef="pure">0.56</nuwe:PercentageOfGrossProfitit>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c119" decimals="-3" id="ixv-5831" unitRef="usd">2371000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c120" decimals="-3" id="ixv-5832" unitRef="usd">1846000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c119" decimals="-3" id="ixv-5833" unitRef="usd">2084000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c120" decimals="-3" id="ixv-5834" unitRef="usd">1430000</us-gaap:SellingAndMarketingExpense>
    <nuwe:Development contextRef="c119" decimals="-3" id="ixv-5835" unitRef="usd">1397000</nuwe:Development>
    <nuwe:Development contextRef="c120" decimals="-3" id="ixv-5836" unitRef="usd">206000</nuwe:Development>
    <nuwe:ClinicalQualityRegulatoryExpenses contextRef="c119" decimals="-3" id="ixv-5837" unitRef="usd">400000</nuwe:ClinicalQualityRegulatoryExpenses>
    <nuwe:ClinicalQualityRegulatoryExpenses contextRef="c120" decimals="-3" id="ixv-5838" unitRef="usd">578000</nuwe:ClinicalQualityRegulatoryExpenses>
    <us-gaap:OperatingExpenses contextRef="c119" decimals="-3" id="ixv-5839" unitRef="usd">6252000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c120" decimals="-3" id="ixv-5840" unitRef="usd">4060000</us-gaap:OperatingExpenses>
    <us-gaap:ShareBasedCompensation contextRef="c119" decimals="-3" id="ixv-5841" unitRef="usd">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c120" decimals="-3" id="ixv-5842" unitRef="usd">67000</us-gaap:ShareBasedCompensation>
    <nuwe:OtherIncomeExpenseAndIncomeTaxes contextRef="c119" decimals="-3" id="ixv-5843" unitRef="usd">27000</nuwe:OtherIncomeExpenseAndIncomeTaxes>
    <nuwe:OtherIncomeExpenseAndIncomeTaxes contextRef="c120" decimals="-3" id="ixv-5844" unitRef="usd">46000</nuwe:OtherIncomeExpenseAndIncomeTaxes>
    <us-gaap:NetIncomeLoss contextRef="c119" decimals="-3" id="ixv-5845" unitRef="usd">-4541000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c120" decimals="-3" id="ixv-5846" unitRef="usd">-3014000</us-gaap:NetIncomeLoss>
    <us-gaap:AssetAcquisitionTextBlock contextRef="c0" id="ixv-3325">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   &lt;span style="font-weight: bold;"&gt;Note 10&#x2014;Asset Acquisition&lt;/span&gt;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   On March 17, 2026, the Company completed the acquisition of Rendiatech Ltd. The transaction was accounted for as an asset acquisition under ASC 805-50 because the acquired set did not meet the definition of a business.
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; Consideration Transferred (in thousands):&lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;
   &lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td style="width: 88%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      &lt;span style="font-weight: bold;"&gt;Description&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align: middle; text-align: center; width: 1%;"&gt;


      &lt;span style="font-weight: bold;"&gt;Amount&lt;/span&gt;
     &lt;/td&gt;&lt;td style="vertical-align: middle; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Cash paid at closing
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%;"&gt;149&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Less: Cash acquired
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%; border-bottom: 2px solid black;"&gt;(24&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%; border-bottom: 2px solid transparent;"&gt;)&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      &lt;span style="font-weight: bold;"&gt;Net cash consideration&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; font-weight: bold; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; font-weight: bold; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; font-weight: bold; width: 9%;"&gt;125&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; font-weight: bold; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt; &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt; Fair value of common stock issued (150,000 shares) &lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%;"&gt;162&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Transaction costs capitalized
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%;"&gt;203&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Additional cash payments
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%; border-bottom: 2px solid black;"&gt;313&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      &lt;span style="font-weight: bold;"&gt;Total consideration transferred&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; font-weight: bold; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; font-weight: bold; width: 1%; border-bottom: 2px solid black;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; font-weight: bold; width: 9%; border-bottom: 2px solid black;"&gt;803&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; font-weight: bold; width: 1%; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
  &lt;/table&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;Assets Acquired and Liabilities Assumed (in thousands): &lt;/div&gt;&lt;div&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;
   &lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td style="width: 88%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      &lt;span style="font-weight: bold;"&gt;Description&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align: middle; text-align: center;"&gt;


      &lt;span style="font-weight: bold;"&gt;Fair Value&lt;/span&gt;
     &lt;/td&gt;&lt;td style="vertical-align: middle; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;

   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Inventory
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;span style="font-weight: 700; letter-spacing: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%;"&gt;50&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      In-process R&amp;amp;D
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%;"&gt;757&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Non-compete agreements
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%;"&gt;27&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Liabilities assumed
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%; border-bottom: 2px solid black;"&gt;(31&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%; border-bottom: 2px solid transparent;"&gt;)&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      &lt;span style="font-weight: bold;"&gt;Net assets acquired&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; font-weight: bold; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; font-weight: bold; width: 1%; border-bottom: 2px solid black;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; font-weight: bold; width: 9%; border-bottom: 2px solid black;"&gt;803&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; font-weight: bold; width: 1%; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
  &lt;/table&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;&lt;div style="margin: 0in;"&gt;The
IPR&amp;amp;D asset had no alternative future use in its acquired form and was
charged to research and development expense immediately ($757 thousand) in
accordance with ASC 730-10-25-2. The non-compete agreements are being amortized
over their three-year estimated useful lives.&lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   There were no operations from the acquired Rendiatech assets between the acquisition date and March 31, 2026. The transaction was not material to the Company&#x2019;s results of operations or cash flows.&lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;&lt;div style="margin: 0in;"&gt;The
additional cash payments represent $125 thousand due on or prior to December
31, 2026 and $250 thousand due on the earlier of a defined commercial
regulatory clearance date or December 31, 2027. The payments were discounted to
fair value as of the acquisition date.&lt;/div&gt;&lt;div style="margin: 0in;"&gt;&#160;&lt;/div&gt;&lt;div style="margin: 0in;"&gt;In
connection with the asset acquisition, the Company is obligated to pay an
earnout royalty payment equal to 9% of gross sales by the Company on the sale
of the commercialized products, not to exceed $2 million. The Company
determined the earnout was considered a post-acquisition cost and will
recognize expense once a payment amount is considered probable and reasonably
estimable.&lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; As of March 31, 2026, the net carrying amount of acquired intangible assets from the Rendiatech transaction was $27 thousand (non-compete agreements, net of amortization). The Company&#x2019;s separately capitalized website intangible is included in the total Intangible assets, net balance of $112 thousand. &lt;/div&gt;</us-gaap:AssetAcquisitionTextBlock>
    <us-gaap:AssetAcquisitionTableTextBlock contextRef="c0" id="ixv-3331">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt; Consideration Transferred (in thousands):&lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;
   &lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td style="width: 88%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      &lt;span style="font-weight: bold;"&gt;Description&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align: middle; text-align: center; width: 1%;"&gt;


      &lt;span style="font-weight: bold;"&gt;Amount&lt;/span&gt;
     &lt;/td&gt;&lt;td style="vertical-align: middle; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Cash paid at closing
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%;"&gt;149&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Less: Cash acquired
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%; border-bottom: 2px solid black;"&gt;(24&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%; border-bottom: 2px solid transparent;"&gt;)&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      &lt;span style="font-weight: bold;"&gt;Net cash consideration&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; font-weight: bold; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; font-weight: bold; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; font-weight: bold; width: 9%;"&gt;125&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; font-weight: bold; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt; &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt; Fair value of common stock issued (150,000 shares) &lt;/div&gt; &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%;"&gt;162&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Transaction costs capitalized
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%;"&gt;203&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Additional cash payments
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%; border-bottom: 2px solid black;"&gt;313&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      &lt;span style="font-weight: bold;"&gt;Total consideration transferred&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; font-weight: bold; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; font-weight: bold; width: 1%; border-bottom: 2px solid black;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; font-weight: bold; width: 9%; border-bottom: 2px solid black;"&gt;803&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; font-weight: bold; width: 1%; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
  &lt;/table&gt;</us-gaap:AssetAcquisitionTableTextBlock>
    <us-gaap:PaymentsToAcquireProductiveAssets contextRef="c123" decimals="-3" id="ixv-5847" unitRef="usd">149000</us-gaap:PaymentsToAcquireProductiveAssets>
    <nuwe:AssestAcquisitionCashAcquired contextRef="c123" decimals="-3" id="ixv-5848" unitRef="usd">24000</nuwe:AssestAcquisitionCashAcquired>
    <us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration contextRef="c123" decimals="-3" id="ixv-5849" unitRef="usd">125000</us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c123"
      decimals="INF"
      id="ixv-5850"
      unitRef="shares">150000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable contextRef="c123" decimals="-3" id="ixv-5851" unitRef="usd">162000</us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable>
    <us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost contextRef="c123" decimals="-3" id="ixv-5852" unitRef="usd">203000</us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost>
    <nuwe:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditionalCashPayments contextRef="c123" decimals="-3" id="ixv-5853" unitRef="usd">-313000</nuwe:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditionalCashPayments>
    <us-gaap:AssetAcquisitionConsiderationTransferred contextRef="c123" decimals="-3" id="ixv-5854" unitRef="usd">803000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="c0" id="ixv-3401">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;Assets Acquired and Liabilities Assumed (in thousands): &lt;/div&gt;&lt;div&gt;&#160;&lt;/div&gt;&lt;table cellpadding="0" style="font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; width: 100%; border-spacing: 0px;"&gt;
   &lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td style="width: 88%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle; text-align: center;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      &lt;span style="font-weight: bold;"&gt;Description&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td colspan="2" style="vertical-align: middle; text-align: center;"&gt;


      &lt;span style="font-weight: bold;"&gt;Fair Value&lt;/span&gt;
     &lt;/td&gt;&lt;td style="vertical-align: middle; text-align: center; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;

   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Inventory
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;span style="font-weight: 700; letter-spacing: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%;"&gt;50&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      In-process R&amp;amp;D
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%;"&gt;757&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Non-compete agreements
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%;"&gt;27&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1pt; background-color: rgb(204, 238, 255);"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      Liabilities assumed
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%; border-bottom: 2px solid black;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; width: 9%; border-bottom: 2px solid black;"&gt;(31&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; width: 1%; border-bottom: 2px solid transparent;"&gt;)&#160;&lt;/td&gt;
   &lt;/tr&gt;
   &lt;tr style="vertical-align: top; height: 1.0pt;"&gt;
    &lt;td style="vertical-align: middle;"&gt;
     &lt;div style="text-indent: -7.2pt; padding-left: 7.2pt;"&gt;
      &lt;span style="font-weight: bold;"&gt;Net assets acquired&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="vertical-align: middle; text-align: right; font-weight: bold; width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; font-weight: bold; width: 1%; border-bottom: 2px solid black;"&gt;$&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: right; font-weight: bold; width: 9%; border-bottom: 2px solid black;"&gt;803&lt;/td&gt;&lt;td style="vertical-align: middle; text-align: left; font-weight: bold; width: 1%; border-bottom: 2px solid transparent;"&gt;&#160;&lt;/td&gt;
   &lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory contextRef="c124" decimals="-3" id="ixv-5855" unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <nuwe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInProcessResearchAndDevelopment contextRef="c124" decimals="-3" id="ixv-5856" unitRef="usd">757000</nuwe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInProcessResearchAndDevelopment>
    <nuwe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompeteAgreements contextRef="c124" decimals="-3" id="ixv-5857" unitRef="usd">27000</nuwe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNonCompeteAgreements>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities contextRef="c124" decimals="-3" id="ixv-5858" unitRef="usd">31000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet contextRef="c124" decimals="-3" id="ixv-5859" unitRef="usd">803000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <nuwe:NoncashInProcessResearchAndDevelopmentfromRendiatechAcquisition contextRef="c0" decimals="-3" id="ixv-5860" unitRef="usd">757000</nuwe:NoncashInProcessResearchAndDevelopmentfromRendiatechAcquisition>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c121" id="ixv-5861">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <nuwe:AdditionalCashPaymentsDueWithInOneYear contextRef="c2" decimals="-3" id="ixv-5862" unitRef="usd">125000</nuwe:AdditionalCashPaymentsDueWithInOneYear>
    <nuwe:AdditionalCashPaymentsDueAfterOneYear contextRef="c2" decimals="-3" id="ixv-5863" unitRef="usd">250000</nuwe:AdditionalCashPaymentsDueAfterOneYear>
    <nuwe:EarnoutRoyaltyRateOnGrossSales contextRef="c0" decimals="INF" id="ixv-5864" unitRef="pure">0.09</nuwe:EarnoutRoyaltyRateOnGrossSales>
    <nuwe:EarnoutRoyaltyPaymentMaximumAmount contextRef="c2" decimals="INF" id="ixv-5865" unitRef="usd">2000000</nuwe:EarnoutRoyaltyPaymentMaximumAmount>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c122" decimals="-3" id="ixv-5866" unitRef="usd">27000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c2" decimals="-3" id="ixv-5867" unitRef="usd">112000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:SubsequentEventsTextBlock contextRef="c0" id="ixv-3475">&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   &lt;span style="font-weight: bold;"&gt;Note 11&#x2014;Subsequent Events&lt;/span&gt;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;&lt;div style="margin: 0in;"&gt;Subsequent to March 31, 2026, on April 24, 2026, the Company
entered into a Settlement Agreement and Release with E.F. Hutton &amp;amp; Co. The
Company agreed to pay a total of $204 thousand in full settlement of all
claims, with neither party admitting any liability. The payment was due and
paid within five days of the settlement date, and E.F. Hutton &amp;amp; Co. has
agreed to dismiss the lawsuit with prejudice. The Company had accrued the full
$204 thousand settlement amount as of March 31, 2026. This settlement resolves
the matter in its entirety.&lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;&#160;
  &lt;/div&gt;&lt;div style="font-family: TimesNewRoman, &amp;quot;Times New Roman&amp;quot;, Times, Baskerville, Georgia, serif; font-size: 10pt;"&gt;
   The Company has evaluated subsequent events through May 15, 2026, the date these condensed consolidated financial statements were available to be issued, and has determined that, other than the matters described above, there are no additional subsequent events requiring recognition or disclosure in the financial statements.
  &lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:LitigationSettlementExpense
      contextRef="c125"
      decimals="INF"
      id="ixv-5868"
      unitRef="usd">204000</us-gaap:LitigationSettlementExpense>
    <nuwe:SettlementPaymentDuePeriodDays contextRef="c125" id="ixv-5869">P5D</nuwe:SettlementPaymentDuePeriodDays>
    <us-gaap:LitigationSettlementExpense contextRef="c0" decimals="INF" id="ixv-5870" unitRef="usd">204000</us-gaap:LitigationSettlementExpense>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c0" id="ixv-5871">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c0" id="ixv-5872">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c0" id="ixv-5873">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c0" id="ixv-5874">false</ecd:Rule10b51ArrAdoptedFlag>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c2"
      id="hidden-fact-0"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c3"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c87" id="hidden-fact-2">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="c83"
      decimals="INF"
      id="hidden-fact-3"
      unitRef="pure">0.024</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-5881">0001506492</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c0" id="ixv-5882">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0" id="ixv-5883">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate contextRef="c0" id="ixv-5884">--12-31</dei:CurrentFiscalYearEndDate>
</xbrl>
